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vAbstract
Cell migration plays an essential role in development and homeostasis. This extraordinarily
complex process, which is dynamically regulated by a coordinated interplay between the
extracellular environment and intracellular signaling pathways, can also cause the emergence
of disease states when dysregulated. A prominent example is cancer metastasis, which is the
leading cause of cancer-related mortality. Despite an increasing body of literature focused
on cell migration, many aspects remain unclear. In the current work, two complementary
systematic in vitro cell migration studies were performed to gain insights into both healthy
immune cell migration and pathological cancer cell migration.
Temperature-dependent neutrophil migration was analyzed using differentiated HL-60 cells
as a model cell line. Neutrophils are the first cells to be activated during inflammation and
subsequently migrate toward an injured tissue or infection site. This response is dependent on
both biochemical signaling and the extracellular environment, one aspect of which includes
increased temperature in the tissues surrounding the inflammation site. The results of this
study reveal a positive correlation between the average speed of randomly migrating cells and
temperatures from 30 ◦C to 42 ◦C. Higher temperatures also induce a concomitant increase
in cell detachment. Further analysis of the migration data showed that persistence time is
higher at low temperatures, while migration persistence length remains constant throughout
the temperature range. Coupled with the increased speed observed at elevated temperatures,
the obtained results indicate the ability of neutrophils to adapt their migration characteristics
to the temperature in order to maintain relatively constant persistence length. As temperature
gradients exist on both cellular and tissue scales, the ability of the HL-60 cells to sense
and react to the presence of temperature gradients, a process known as thermotaxis, was
also investigated. Towards this aim, a two-dimensional temperature gradient chamber was
developed. In a gradient with the range of 27-43 ◦C both positive and negative thermotaxis
was observed with cells migrating both to the high and the low temperature sources. To date,
thermotaxis in neutrophil differentiated HL-60 cells has never been reported.
Next, an in-depth in vitro migration study was carried out on Panc1 pancreatic cancer cells to
elucidate the role of Protein Kinase D (PKD) in cancer cell migration. CRISPR-mediated
vi
knockouts of PKD1, 2, and 3 in Panc1 cells were used to investigate isoform-specific effects
on cancer cell invasion-related motility. The data presented in this project reveals that absence
of each PKD isoform plays a significant role in cell speed and migration persistence. To
investigate the pancreatic cancer PKD isoform-dependent contact guidance, a panel of more
complex PDMS-based substrates containing microgrooves of different heights and widths
was utilized. These experiments further demonstrate pancreatic cancer cell shape, speed, and
contact guidance dependence on the presence of different PKD isoforms. Based on these
findings, in combination with previous works showing that contact guidance is affected by
cell viscoelasticity, mechanical properties of each PKD isoform knockout cell line were also
measured using a laser-based optical cell stretcher. These experiments showed a significant
increase in Panc1 cell deformability in the absence of PKD1, demonstrating for the first
time PKD involvement in regulation of cellular mechanical properties. Finally, these basic
mechanical properties were correlated to MMP - independent confined migration, which is
required for cells to metastasize in vivo.
vii
Zusammenfassung
Die Migration von Zellen spielt eine zentrale Rolle bei der Entwicklung und Homöostase von
Geweben, Organen und Organsimen. Der komplexe Prozess der Zellmigration, der durch ein
koordiniertes Zusammenspiel aus Signalen zwischen der extrazellulären Umgebung und den
intrazellulären Signalwegen dynamisch reguliert wird, kann bei verschiedenen Erkrankun-
gen auch fehlreguliert sein. Ein prominentes Beispiel hierfür ist die Metastasierung von
Krebs, ein Prozess, der die Hauptursache der krebsbedingte Mortalität darstellt. Trotz der
zunehmenden Anzahl an Literatur, die sich thematisch auf die Tumorzellmigration konzentri-
ert, sind viele Aspekte der Zellmigration noch unklar. In der Arbeit zu dieser Dissertation
wurden zwei komplementäre systematische Zellmigrationsstudien durchgeführt, um Einblicke
in die Immunzellmigration und die pathologische Krebszellmigration zu erhalten.
Die temperaturabhängige Migration von Neutrophilen Granulozyten wurde unter Verwendung
differenzierter HL-60-Zellen als Modellzelllinie analysiert. Periphere Neutrophile im Blut
sind die ersten Zellen, die während einer Entzündung aktiviert werden und anschließend in
Richtung eines verletzten Gewebes oder einer Infektionsstelle wandern, ebenso reichern sie
sich in Tumoren an. Diese gerichtete Migration hängt sowohl von biochemischen Signalen,
als auch von physikalischen Eigenschaften und Signalen der extrazellulären Umgebung ab.
Interessanterweise zeigen Geweben um Entzündungsstelle herum eine erhöhte Temperatur
und haben somit zum umliegenden Gewebe auch einen Temperaturgradienten. Allerdings ist
wenig über die Migration von Zellen, insbesondere Granulozyten bei erhöhter Temperatur
oder in solchen Temperaturgradienten bekannt. Die hier beschriebene in vitro Untersuchung
zeigt, dass die Migrationsgeschwindigkeit positiv mit der Erhöhung der Temperatur zwischen
30 ◦C und 42 ◦C, korreliert. Die Persistenz-Zeit der Migration war bei niedrigen Temperaturen
höher als bei hohen Temperaturen, während das Produkt aus mittlerer Geschwindigkeit und
Persistenz-Zeit, also ein Maß für die Persistenzlänge, im gesamten Temperaturbereich etwa
konstant blieb. Da Temperaturgradienten sowohl auf Zell- als auch auf Gewebeebene ex-
istieren, wurde darüber hinaus die Fähigkeit der Zellen untersucht, auf Temperaturgradienten
zu reagieren. Unter Verwendung einer zweidimensionalen Temperatur-Gradientenkammer mit
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einer Temperaturdifferenz von 27–43 ◦C wurde sowohl positive als auch negative Thermotaxis
bei den HL-60 Zellen beobachtet.
Des Weiteren wurde eine detaillierte biophysikalische in-vitro-Migrationsstudie mit Panc1-
Bauchspeicheldrüsenkrebszellen durchgeführt, um die Rolle verschiedener Isoformen der Pro-
tein Kinase D (PKD) bei der Migration besser zu verstehen. Dazu wurden CRISPR-vermittelte
Knockouts von PKD1, 2 und 3 in Panc1-Zellen verwendet, um isoform-spezifischer Effekte
auf das invasive Verhalten der Zellen zu untersuchen. Der spezifische knock-down jeder einzel-
nen PKD-Isoform hatte Einfluss auf die Migrationsgeschwindigkeit und die Zellmorphologie,
sowie auf die Fähigkeit der Zellen, durch enge Mikrokanäle (Confinement) zu wandern.
Ebenso konnte gezeigt werden, dass die Zellmorphologie, die Migrationsgeschwindigkeit
und die sogenannte Contact Guidance, die Migration und Orientierung entlang von Mikroto-
pographien von der Präsenz der verschiedenen PKD-Isoformen beeinflusst wird. Da frühere
Arbeiten zeigen, dass das Contact Guidance Verhalten durch die Viskoelastizität der Zellen
beeinflusst wird, wurden die mechanischen Eigenschaften der PKD-Isoform-Knockout-Zellen
mit einem lasergestützten optischen Zellstrecker bestimmt. Die Ergebnisse zeigen eine sig-
nifikante Zunahme der Verformbarkeit von Panc1-Zellen in Abwesenheit von PKD1, jedoch
weitaus geringere Veränderungen beim Knock-Down der beiden anderen Isoformen. Somit
scheint PDK1 in Panc1-Zellen singulär zellmechanische Eigenschaften zu verändern, die für
die Migration wichtig sind.
ix
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Cell migration
Migration is imperative for life. It occurs on a wide range of spatio-temporal scales, starting
with cellular locomotion necessary for development and maintenance of a living organism
and reaching to animal migration in search for food. Cell migration is a highly complex
process essential for embryonic development, immune response, tissue genesis and repair [1–
6]. It requires a dynamic interplay between the intracellular signaling pathways and the
extracellular environment. Although the biological and physical mechanisms of basic cell
migration have been extensively studied, many questions still remain unanswered. A detailed
understanding of this processes in cell migration is especially important, as the main cause of
cancer-related death is cancer metastasis, i.e. relocation of cancer cells into distant organs
and new tumor formation. The complexity of the underlying mechanisms of cell migration
arises from the vast number of cell types and tissues that motile cells have to navigate and the
presence of different migrational phenotypes. For example, individually migrating epithelial
cells adapt mesenchymal migration mode which is characterized by strong attachment to the
surrounding matrix and high cell contractility, whereas leukocytes, which need to migrate
in diverse environments, largely engage in so called amoeboid migration, which does not
involve cell-matrix anchorage [7].
1.1 Cell migration modes
There are two major categories of cell migration: single and collective (Fig. 1.1) [7]. Single
cell locomotion can be further divided into two modes known as amoeboid and mesenchymal
migration. Fast cells, such as leukocytes, fish keratinocytes and Dictyostelium discoideum, all
undergo amoeboid movement [8, 9]. One common characteristic of cells migrating in amoe-
boid fashion is continuous change in cell morphology driven by rapid protrusion and retraction
of cell extension either by plasma membrane blebbing or pseudopod formation [7], [10]. Cells
moving in this fashion do not adhere strongly to the surface and depend on active filamentous
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Figure 1.1: Cells can move in single (amoeboid and mesenchymal) and collective fashion (mul-
ticellular streaming and epithelial cell sheet migration). Migration modes depend on cell type and
extracellular environment (extracellular matrix (ECM) composition, structure and gap size). As cells
exhibit high degree of plasticity they can alternate between different migration modes (shown by the
arrows). Adapted from Friedl et al. [7].
actin (F-actin) polymerization (pseudopodal migration) and actomyosin contraction (amoe-
boid blebbing) [10–12]. Mesenchymal single cell locomotion can be described by a multi-step
cycle: F-actin polymerization at the leading edge creates an organelle-free membrane protru-
sion, which subsequently, through integrin-mediated attachment (focal adhesions), becomes
anchored to the substrate. Consecutive, actomyosin contractility and cell detachment at
the rear end results in forward cell movement. Mesenchymal migrating cells usually have
spindle-shaped elongated morphology [7].
Interestingly, cells can also adapt to molecular and environmental changes by altering their
migration mechanisms [9]. The most prominent example is epithelial-to-mesenchymal and
mesenchymal-to-epithelial transitions (EMT and MET, respectively) observed in metastatic
cancer cells [13, 14].
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Collective cell migration occurs when group of cells migrate in a coordinated fashion by
retaining their cell-cell contacts (Fig. 1.1). It is comparable to individual mesenchymal cell
migration, with similar front-rear polarity and traction forces generated at the front of the
collective [15]. The major difference is that cell-cell junctions play mechanosensitive signal
and force transmission role from the leader cells towards the rear [16, 17]. This ensures a
well-coordinated grouped forward movement with the posterior cells following the leader cells.
Epithelial collective migration is characterized by tightly connected cell sheets with strong
cell-cell junctions [17]. It is an important part of wound healing and morphogenesis, but is also
common in pathological processes such as cancer metastasis [14]. Mesenchymal collective
migration, also known as multicellular streaming, is characterized by looser arrangements
and transient adherence junctions between cells [17]. This kind of behavior is observed,
for example, in neural crest cells, key participants of vertebrate embryogenesis [3]. As in
epithelial collective migration, cell streaming is also common in malignant invasion and
metastasis [14].
Independent of migration mechanism, cell polarization, F-actin polymerization and myosin II-
driven contractility are the dominant mediators of cell migration [18, 19]. This is strongly
collaborated by the studies of blood polymorphonuclear cells (PMN) and fish keratinocytes
in which the authors produced motile cytoplasmic fragments from the leading front of the
migrating cells, lacking nuclei, microtubules and rest of the organelles [20–22].
1.2 Quantitative characterization of single cell migration
There are many models and theories describing cell migration phenomenologically and based
on the underlying molecular mechanisms [23]. Cell migration is quantitatively characterized
by a number of parameters, including speed, velocity and directional persistence [24]. Cell
speed and velocity are easy enough to calculate by tracking cell displacement over sufficient
amount of time. However, these two parameters are not sufficient to fully represent cell
migration. Moving cells have varying degrees of intrinsic persistence even in the absence of
extracellular guiding signals [24, 25]. It is becoming more and more clear that cells utilize
non-Brownian migration patterns in order to efficiently search for their targets [26–28]. For
example, in T cells which explore tissues through Lévy walk (alternating numerous short
steps with longer straight steps in-between), a type of migration mechanism also observed in
many animals when hunting for food [26, 27, 29]. Dictyostelium discoideum, a model single
cell organism, also exhibit non-diffusive forward motion and migrate in a zigzag fashion
by “remembering” their last turn direction [28]. Many quantitative parameters have been
developed to characterize cell persistence, such as mean square displacement (MSD) and
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direction autocorrelation (Fig. 1.2). The common assumption of these two methods is that the
persistency with which the cells migrate is high at short time periods and decays exponentially
over long time intervals. Thus, persistence time is the time period in which the cells exhibit
correlated migration in one direction.
Figure 1.2: Cell tracking, mean square displacement (MSD) and directional autocorrelation
analysis. A. Actual (left) and tracked (right) cell migration paths. Blue dots, representing cell
nucleus, are tracked positions of the cells (1 to 5 in this example) with a set of (x,y) coordinates.
Δt is the minimal time interval between two consecutive tracked positions (usually kept constant).
B. At any given time interval t, with t = nΔt, overlapping squared displacement is calculated and
averaged over all cells tracked and all possible displacement combinations for that specific t interval
(see Equation 1.1). C. Direction autocorrelation represents correlation between the angles that the
normalised displacement vectors (rˆ) form over increasing time intervals Equation 1.2. Autocorrelation
values are given by , where cos (θ) is the angle difference between two vector angles (α). As with
MSD analysis, the autocorrelation at time interval t is averaged over all cells tracked. Figure C was
partially adapted from Gorelik et al. [24].
There are two types for MSD analysis based on overlapping and non-overlapping intervals
between frames. Overlapping MSD method is the mostly one used as it provides more data
sets for the averaging process (Fig. 1.2 B) [24, 30]. In 2D, for any time interval t (t = nΔt)
MSD is given by [31]:
〈r2 (t)〉= 1
N−n+1
N−n
∑
i=0
[
(x(i+n)t− xit)2 +(y(i+n)t− yit)2
]
, (1.1)
where N is the total number of steps tracked and n is the step size (Fig. 1.1B). The square
brackets denote averaging for each time point over all tracked cell number. The average MSD
is then plotted versus the time interval as shown in Figure 1.3.
Mean square displacement has a time interval dependence that follows a power law MSD ∝ tβ ,
with 0 < β< 2. The linear dependence is associated with Brownian motion, i.e. diffusive
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random walk. Deviation from the linear behavior denotes subdiffusive, constraint (e.g. 3D
migration with 0 ≤ β≤ 1) or superdiffusive (e.g. Lévy walk with 1 ≤ β≤ 2) migration modes.
As mentioned above, in the absence of an extracellular guiding signal, cells migrate in a
correlated manner in shorter time intervals and at longer observation periods they lose the
persistency (β ∼ 1). To quantify time dependent changes in β(t), the logarithmic derivative
of MSD (β(t)) over time is used (see Materials and Methods, Equation 5.5) [32]. In order
to extract the persistence time, MSD curves are usually fitted with persistent random walk
model (PRW) (see Materials and Methods, Equation 5.4). It is worth mentioning here that it
is customary to use only 1/3 of the MSD data for fitting purposes, as with increasing time
intervals less data points are available hence increasing the margin of error [24, 32].
Figure 1.3: Subdiffusive, diffusive and superdiffusive migration modes characterized by mean
square displacement (MSD). Diffusive random walk is the random migration with no or short-
ranged persistence. Any kind of deviation from diffusive (sub- or superdiffusive) behavior is called
anomalous random migration. Random migration occurs when the intrinsic positive feedback loop
control, stabilizing the leading edge of the cell is weak [25]. Subdiffusive migration is characteristic
for 3D confined migration whereas Lévy walk is an example of superdiffusive migration mode. Image
was adapted from Krummel et al. [26].
Mean square displacement of multiple tracked cells represents, in essence, the average area
that the cells explored in the given time interval [24]. In contrast, direction autocorrelation
(DA) evaluates purely the directional component (not biased by cell speed) as it represents the
correlation between angles that the normalised displacement vectors make (Fig 1.2C) [24].
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Directionality autocorrelation is given by:
DA =
1
N−n+1
N−n
∑
i=0
(
rˆ(i+n)t · rˆit
)
=
1
N−n+1
N−n
∑
i=0
(
cos(α(i+n)t− cosαit)
)
, (1.2)
where α is the angle at each time point of trajectory and t is the time interval. Similarly to
MSD analysis, DA for a given t is averaged over the number of cells tracked and plotted over
time interval (Fig. 1.2C). The higher the direction autocorrelation values the more persistent
is the cell migration. The persistence time is then evaluated through exponential fitting of the
autocorrelation curves ∼ e−t/τ , where τ is the persistence time. One limitation of direction
autocorrelation is that it is sampling interval (Δt) dependent. As the sampling time intervals
decrease towards zero, the confounding effects of diffusive motion and human error in cell
position measurement are amplified. On the other hand with very large sampling intervals
displacement direction may seem not correlated at all [32].
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Temperature effects and neutrophils
With the constant feedback loop between cell intrinsic signaling pathways and extrinsic
environment, any changes in the latter may lead to both positive and negative alterations
in cell behavior. In context of cell migration, cell speed and directional persistence can be
influenced by external factors such as ECM structure, composition or stiffness, application of
physical strain or electrical fields, presence of chemoattractants and temperature [33–38]. One
of the projects in this thesis focused on investigation of temperature-dependent neutrophil
migration studies using differentiated HL-60 model cell line.
2.1 Role of temperature in cell physiology
Temperature is not constant in the human body with temperature gradients existing on both
the single cell level and the tissue-scale level [39–41]. These gradients play an important role
in many physiological processes such as metabolism, cell division and gene expression [42].
Regulated by the hypothalamus, healthy body’s core temperature is kept at approximately
37 ◦C, whereas at the surface the temperatures range from 28 to 33 ◦C [43]. During disease,
body core temperature may rise up to approximately 41 ◦C. On the cellular level, Chrétien et
al. recently demonstrated that mitochondria, the organelle responsible for synthesis of ATP,
are physiologically maintained at 50 ◦C, approximately 13 ◦C degrees higher than the average
cell temperature [44]. Furthermore, temperature gradients have been shown to influence
embryonic development in Drosophila melanogaster [45]. Mammalian sperm cells also use
temperature cues to navigate the female genital tract [46]. Fluctuations in temperature can
also affect F-actin polymerization, the diffusion rate of signaling molecules and integrins, cell
membrane fluidity and many other processes involved in cell migration [47–50]. Heat and
thermal gradients arise in diseased and inflamed tissues as well [51]. Cancer stroma is quite
often inflamed and exhibits higher than normal temperatures [52]. Moreover, hyperthermia
therapy combined with other, more conventional ones, has been shown to improve patient
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treatment in some cancer types [53–55]. Thus, it is not surprising that temperature can
also affect vital white blood cell functions, including phagocytic activity in monocytes and
superoxide production in neutrophils [56, 57].
2.2 Neutrophils and differentiated HL-60 cell line
Neutrophils, a type of blood polymorphonuclear (PMN) cells, are the most abundant white
blood cells in the human body and are the first cells to respond to infection or tissue dam-
age [58]. One of the main morphological characteristics of these cells is the multi-lobulated
cell nucleus, which plays a key role in neutrophilic functions [59]. The presence of cytoplas-
mic granules containing variety of antimicrobial proteins, proteases, and soluble mediators of
inflammation is another important feature of these leukocytes [60]. Their ability to swiftly
detect signals released by damaged host cells or microorganisms and react by polarizing and
migrating towards the source is crucial to the body’s initial inflammatory response [61]. The
first step in neutrophil activation is rapid F-actin polymerization at the leading edge, polarizing
the cell [62]. Many signaling molecules are involved in this step, and a great deal of work
has been performed to fully understand the mechanism of neutrophil activation and direc-
tional migration [63–65]. Neutrophils make use of multiple mechanisms to fight pathogens:
degranulation, phagocytosis or by releasing neutrophil extracellular traps (NETs) [60, 66].
Degranulation causes a problem when working with blood neutrophils, as cells can easily
destruct during isolation.
One interesting study on neutrophils relevant to the work presented in this thesis is the
possibility of motile cellular fragment formation from blood neutrophils. Malawista et al. has
shown that there is an uncoupling of actin- and glycogen- rich neutrophil cytoplasm from the
cell body when heated briefly at temperatures close to 45 ◦C [20, 67–69]. Even in the absence
of all the organelles, such as the nucleus and microtubule, this cell fragments, or as the
authors named them cytokineplasts (CKP), retained many of the characteristics of the parental
cells, such phagocytosis, chemotaxis and some residual antimicrobial capacity [69], [20].
The latter was even shown in vivo [20]. Additionally, the lack of granules makes the CKPs
cryopreservable, which is impossible with the blood neutrophils [20]. One of the apparent
advantages of these fragments is their use as a system for identifying minimal components
necessary for cell migration. Despite that, it seams that the research of this system was done
exclusively by Malawista et al. One explanation may be that CKP formation is not a given
and depends on neutrophil isolation method. Additionally, as anyone working with blood
cells knows, many results are donor-dependent (personal observation). To overcome this
issues a model cell line could be used.
11 CHAPTER 2. TEMPERATURE EFFECTS AND NEUTROPHILS
One of the most common model cell lines used for in vitro studies of neutrophil migration are
differentiated HL-60 cells [70–72]. This cell line was first isolated from a patient with acute
promyelocytic leukemia in the 1980s. When incubated with Dimethylsulfoxide (DMSO) or
all-trans-retionoic acid, these cells mature into fully differentiated neutrophils [73, 74]. Unlike
neutrophils isolated from human blood, which are terminally differentiated, short-lived, and
cannot be genetically manipulated, HL-60 cells are immortal and can be transfected [75].
Hauert et al. systematically compared the response of human peripheral blood neutrophils
and neutrophil-differentiated HL-60 cells to different chemical stimuli. They showed that
changes in cell morphology and chemotaxis occurring in response to chemoattractants and
different inhibitors are both quantitatively and qualitatively comparable to those induced in
primary neutrophils. Moreover, they found that levels of signaling enzymes and proteins in
HL-60 cells upon differentiation are similar to those found in primary neutrophils [76]. In the
presented thesis, the response of neutrophil-differentiated HL-60 cells to temperature changes
in their environment was investigated.
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Chapter 3
Pancreatic Cancer
According to the World Health Organization cancer is the second leading cause of death
worldwide. Cancer is a universal term used to describe a wide variety of heterogenic diseases
with their defining feature being uncontrolled in division and spreading of abnormal cells
caused by genetic and/or epigenetic mutations. Out of the wide variety of cancer types,
pancreatic cancer is one of the deadliest with a 5-year survival rate of the patients being
only 7-9 % [77]. This dismal prognosis is notably due to the fact that pancreatic cancer is
extremely difficult to diagnose at early stages [78]. Furthermore, the progression of the tumor
is very rapid: On average it takes only 1.3 years for this cancer to progress from stage I
(carcinoma in situ) to stage IV (highly metastatic with multiple secondary tumors), and by the
time patients exhibit any symptoms more than 50 % of them have secondary tumors [78, 79].
Currently the only effective treatment for pancreatic cancer is surgery, but the statistics show
that by the time of diagnoses only in 20 % of patients the tumor is resectable [78]. Lack of
viable treatments and poor survival rates associated with this cancer type drive the science
community worldwide to investigate further the underlying processes involved in pancreatic
cancer formation, development and to look for new avenues for treatments.
3.1 Progression of pancreatic ductal adenocarcinoma
The pancreas is responsible for synthesis and secretion of hormones (endocrine gland) as
well as digestive enzymes (exocrine gland) [80]. There are several varieties of pancreatic
tumors, but the majority of them are initiated in the exocrine cells of the pancreas (acini
and duct cells) [80, 81]. The most common (90 % of all pancreatic tumors) and aggressive
pancreatic cancer is pancreatic ductal adenocarcinoma (PDAC) [80]. The name derives from
the fact, that PDAC cells share similar histological and molecular characteristics with ductal
cells of the healthy exocrine pancreas [80]. PDAC initiation and progression is associated
with combination of multiple oncogenic mutations, inflammatory processes (e.g. chronic
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pancreatitis) and inactivation of tumor suppressor genes [80, 82, 83]. Indeed, studies show
that pancreatic cancer cells can have hundreds of genetic mutations, which affect numerous
signaling pathways and processes [84]. This tumor driving changes can affect not only ductal
cells, but also acinar cells. In a process called acinar-to-ductal-metaplasia (ADM), mature
acini cells may undergo a transdifferentiation process, forming duct-like PDAC precursor
cells [85, 86]. On condition of further oncogenic events these duct-like cells eventually
progress into precancerous lesions called pancreatic intraepithelial neoplasia (PanINs) and
into malignant adenocarcinoma [87, 88].
Numerous studies have revealed, that one of the crucial tumorigenic events in early PDAC de-
velopment, is the activation of point mutations in the KRAS gene (Ki-ras2 Kirsten rat sarcoma
viral oncogene homolog) [89]. Mutational activation of the KRAS is indeed found in approxi-
mately 90-95 % of pancreatic tumor cells both at early (ADM and PanIN 1, 2 and 3) and late,
invasive, stages [90]. The KRAS protein is a small GTP-binding transducer protein involved
in activation of several signaling cascades (PI3-K/PDK1/Akt and RAF/MEK1/2/ERK1/2)
governing cell proliferation, differentiation and apoptosis [87]. Mutations in this oncogene
lead to permanently activated KRAS protein promoting abnormal cellular behavior. As in
any type of tumor, KRAS oncogene mutation as a lone factor is not responsible for PDAC
progression. Indeed, these mutations may be present in the pancreas of healthy humans as
well [87]. However studies in mouse models with switchable KRAS showed that inactiva-
tion of this oncogene at early stages hindered tumor progression to more advanced stages,
whereas reactivation resulted in rapid disease progression towards PDAC [91]. Unfortunately,
leveraging this information for PDAC therapeutic treatment has not been possible as chemical
inhibition of the KRAS oncoprotein in vivo, despite decades of research, has failed [92].
KRAS is widely considered undruggable. Currently pursued strategies focus on indirect
inhibition of KRAS activity by interfering with the kinase proteins involved in downstream
signaling pathways [93].
3.2 Carcinogenesis and cancer metastasis
Carcinogenesis is a multi-step process in which healthy cells transform into cancer cells,
i.e. cells that exhibit irregular cell growth, high resistance to cytotoxicity as well as defects
in programmed cell apoptosis. It is accompanied by various cancer-promoting genetic and
epigenetic changes in cells (Fig. 3.1). Depending on tissue type, external factors (e.g. tobacco
use, physical activity etc.) and genetic predisposition carcinogenesis may take years or even
decades [94]. Extended frame of this process is an important factor in preventing cancer,
rather than treating it [95].
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Figure 3.1: Initiation, Promotion and Progression: Three steps of carcinogenesis that char-
acterize the evolvement of normal tissue into invasive cancer. Carcinogenesis is caused by
accumulation of abnormal genetic and epigenetic processes promoting activation of oncogenes, altered
DNA repair, inactivation of tumor suppressor genes, promotion of cell growth proteins etc. During
carcinogenesis the cells develop multitude of defects in growth and proliferation control as well as
resistance to cytotoxicity and apoptosis. The end result of carcinogenesis is invasive cancer with
metastatic properties. The image was adapted from Umar et al. [94].
The first step of carcinogenesis is initiation, which represents a stable irreversible mutation
in cell genes creating so-called oncogenes [94, 96]. These mutations deregulate the nor-
mal cellular pathways responsible for cell proliferation and development. Initiation may
happen randomly or in response to external stimuli, which damage cell DNA [94]. Known
carcinogenic catalysts are irradiation, some specific chemicals and viruses, tobacco, etc.
The first mutation does not necessarily mean development of invasive cancer, but it allows
the possibility of further activation of other oncogenes in the initiated cell and its progeny
in case of prolonged exposure to promoting stimuli. The latter may lead to dysplasia, the
selective proliferation and clonal expansion of the abnormal cells. This is the second step in
carcinogenesis and is called promotion. This step usually takes very long time (years) and is
divided into three categories: mild, moderate and severe dysplasia (Fig. 3.1) [94]. Further
genetic changes, such as disruption of tumor suppressive genes, prompt the progression of
dysplasia into neoplasm or carcinoma in situ (a tumor at the site of its formation). Progression
is the last pre-cancer step and if left untreated it may further develop into invasive cancer with
metastatic properties.
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In the promotion stage of carcinogenesis changes happen not only inside the tumor, but
also in the surrounding tissue (stroma) [97–99]. Tumor stroma comprises of ECM (pri-
marily collagen) and stromal cells, such as cancer associated fibroblasts (CAFs) and im-
mune cells [100, 101]. During disease, changes are induced not only in ECM biochemistry
but also in biomechanical properties. ECM is produced and constantly remodeled by cells
and during carcinogenesis, CAFs are responsible for the abnormal, tumor-promoting ECM
production and reorganization [99, 102]. Additionally CAFs secrete enzymes, which crosslink
collagen fibers inducing decrease in ECM porosity and increase in stiffness, which in turn,
drives disease progression further [97, 98, 103]. Tissue fibrosis, which also contributes to
matrix stiffening [104], can also be a trigger for carcinogenesis, such as in case of chronic
pancreatitis, which quite often precedes or accompanies pancreatic cancer [82, 105]. Besides
biomechanical changes, the ECM orientation is also affected, as instead of the non-oriented,
anisotropic fibrils surrounding healthy epithelia, in malignant tumors ECM fibers appear
straighter and are either aligned parallel or perpendicular to the tumor [106, 107]. This highly
structured stroma orientation in the malignancies provides a highway for the migrating cancer
cells and promotes cancer metastasis [106, 108].
Primary tumors are rarely the cause of patient death [109]. The majority of cancer related
deaths are caused by therapy resistant metastases. Metastasis is defined as the spreading of
malignant cells through blood and lymphatic vessels with subsequent colonization at distant
organs, resulting in one or more secondary tumors [109, 110]. Similar to carcinogenesis,
metastasis is a very complex process, which involves cancer cell dissemination from the
primary tumor, invasion into the stroma, intravasation of cells into blood vessels, survival
and circulation, attachment of the cells to the vessel walls and extravasation, micrometastases
formation and finally metastatic colonization of different tissues (Fig. 3.2) [110]. One crucial
step of metastasis is tumor angiogenesis. Angiogenesis, the establishment of new blood
vessels, likely starts during carcinogenesis, as supply of oxygen and nutrients is necessary for
tumor expansion [111]. During metastasis, angiogenesis provides easily accessible and highly
permeable blood vessels for cancer cell intravasation.
There are two accepted models for tumor metastasis: Linear and parallel [112, 113]. In the
linear model, the metastatic cascade is believed to start at the last stage of carcinogenesis,
when the tumor is fully developed into the invasive phenotype [113]. The second model is
based on the premise that the dissemination and metastasis of tumor cells happens in the
earlier stages and is initiated in parallel to the primary tumor progression [112, 113]. The
latter model is more likely to apply to pancreatic tumor metastasis, as the majority of patients
have metastatic lesions at the time of the initial diagnosis. Indeed Rhim et al., using mouse in
vivo models, have recently shown, that invasion of pancreatic tumor cells into the surrounding
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Figure 3.2: Cell-biological events occurring during the invasion-metastasis cascade. The steps
involved in cancer cell metastasis are: 1) Metastatic cancer cell detachment from the primary tumor,
followed by invasion into the surrounding tissue, 2) intravasation of cells into the blood and lymph
vessels, 3) survival and circulation, 4) arrest of cells at the endothelial walls of the vessels, 5)
extravasation, and finally 6) formation of microtumors, followed by metastatic colonization. The image
was adapted from Valastyan et al. [110].
tissue and blood vessels precedes formation of invasive tumor phenotype at the primary site
[114].
3.3 Cancer cell invasion and motility
Cancer invasion is a heterogeneous process, requiring constant changes in cell morphology
and motility (Fig. 3.3) [100, 115, 116]. Cancer cells display exceptional plasticity and are
dynamically able to adapt to, as well as remodel tumor microenvironment. Local invasion
of basement membrane (BM) and the stroma can be done by collective or single cell migra-
tion [100]. In this work, the focus was given to single cell migration and invasion, as it is of
importance not only during the initial invasion of the stroma, but also during intravasation
into the bloodstream and later extravasation [117].
In order to successfully escape the confined primary tumor, cancer cells have to transition
from epithelial phenotype to highly motile, mesenchymal one. This mechanism by which
cancer cells achieve motility is called epithelial-to-mesenchymal transition (EMT) [13, 118,
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Figure 3.3: Schematic representation of tumor invasion. Cancer cell invasion into the surrounding
tissue is a heterogeneous process accompanied by dissemination of the tumor epithelia, Epithelial-to-
mesenchymal transition (EMT) of tumor cells, changes in cell biomechanical properties, basement
membrane degradation and realignment and stiffening of the tumor surrounding ECM. The image was
adapted from Clark et al. [100].
119]. EMT is the accepted mechanism of PDAC invasion and has been even associated
with development of early drug resistance in many pancreatic cell lines [114, 119, 120]. It
is a complex cell-biological process, which is guided by various intrinsic (gene mutations)
and extrinsic (growth factor signaling) cues [121]. One important EMT pathway is initiated
by overproduction of transforming growth factor β (TGF-β) by CAFs in advanced stages
of carcinogenesis, which leads to reduced E-cadherin expression in cancer cells [122, 123].
E-cadherin is a known epithelial marker and is necessary for maintenance of cell-cell junctions
[124]. Downregulation and loss of E-cadherin has been reported in many invasive cancer cell
lines and is observed in up to 60 % of PDAC cell lines [125–127]. The dynamic interplay
between tumor environment and tumor cells is a central factor of cancer invasion [104].
As it was discussed above, the tumor surrounding stroma undergoes drastic changes, such
as increased stiffness and reduced porosity. The increased stiffness, among other things,
promotes motile cell invadopodia formation and further invasion into the tissue by providing
high number of integrin-mediated adhesion sites in the surrounding ECM [104, 128, 129].
Integrin-mediated signaling has also been shown to enhance cancer cell proliferation [130,
131]. Additionally, changes in the ECM topography and realignment (perpendicular to the
BM) create “tracks” for the cells to migrate further into the stroma [106, 108]. In contrast with
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increased stiffness of tumor stroma, cancer cells, especially the more invasive phenotypes,
have been shown to be softer than their healthy progenitors [132–135]. It was suggested, that
increase in malignant cell deformability plays an important role during cell transgression of
the basement membrane [136]. Degradation of basement membrane and the connective ECM
are hallmarks of invasion as well. Intrinsic genetical mutations as well as extrinsic changes
trigger increased production of matrix metalloproteinases (MMPs) by the malignant cells
[137]. MMPs are enzymes which are responsible for ECM degradation. Malignant cancer
cell deformability combined with abnormal MMP secretion facilitates cell migration through
the stiff tumor stroma.
3.4 Importance of protein kinases in cancer and Protein Ki-
nase D family
Cell functions, such as proliferation, survival, motility and metabolism, are regulated by nu-
merous kinase signaling pathways. Protein kinases (PTKs) are enzymes which phosphorylate
proteins, regulating their biological activity [138]. Deregulation and/or overexpression of
PTKs has been linked with numerous oncogenic processes [139]. Inhibiting kinase activity
has been proven to be a promising avenue in targeted cancer therapy. In 2001, FDA approved
the first protein kinase inhibitor (Imatinib/Gleevec) for the treatment of chronic myeloid
leukemia. Since then, 30 more small molecule inhibitors were further approved for treating
different tumors and more than hundred are still in clinical trials [140]. The human genome
encodes 538 protein kinases and each of them is a potential therapeutic target [141]. In recent
years, Protein Kinase D (PKD) enzymes of serine/threonine kinases were found to be key
players in progression of many malignancies, especially in pancreatic cancer [142–144].
Figure 3.4: Structure of Protein Kinase D 1, 2 and 3 isoforms. All 3 isoforms have high degree of
structural homology in their N-terminal regulatory domain, with two cysteine-rich zink finger domains
(C1a and C1b) and an auto-inhibitory pleckstin homology (PH) region, as well as in the C-terminal
catalytic domain (CD). As an example, PKD1 and 2 have an autophosphorylation site (PKD1S910 and
PKD2S876 ), which is absent in PKD3. The image was adapted from Durand et al. [145].
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Human Protein Kinase D family is a part of calcium/calmodulin-dependent kinase superfamily
(CAMK) and consists of 3 structural isoforms called PKD1 (also known as PKCµ), PKD2
and PKD3. PKDs are at crossroads of diacylglycerol and novel Protein Kinase C (DAG-PKC)
signaling pathways and are important regulatory kinases for cell migration, proliferation,
adhesion, EMT, DNA synthesis, vesicular transport and angiogenesis [145, 146]. PKDs play
an important role in physiological processes such as innate immune response initiation [147],
insulin secretion from pancreatic cells [148] and increase of cardiomyocyte contractility
[149]. All three isoforms share similar domain structures having N-terminal regulatory and C-
terminal catalytic domains. They have a high degree of homology in their N-terminal domain,
whereas the C-terminal is not conserved (Fig. 3.4). Despite the high structural homology, all
3 isoforms have been shown to participate in different, quite often non-overlapping signaling
pathways [146]. The latter may be attributed to differences in their expression patterns in
different tissues as well as their structural differences in the phosphorylation motifs. For
example, PKD1 and PKD2 contain C-terminal autophosphorylation site (PKD1S910 and
PKD2S876), which is absent in PKD3 (Fig. 3.4). Subcellular localization also differs for these
isoforms. Under resting conditions PKD1 and PKD2 are localized mainly in the cytoplasm
and to a lesser degree in the Golgi Apparatus or mitochondria [150]. In contrast PKD3, in
addition to cytoplasm localization, can also be found in the nucleus [151].
3.5 Protein Kinase D isoforms in cancer
In recent years more and more studies have reported on PKD involvement in a variety of signal
transduction pathways regulating development and progression of cancer [142, 152–154].
Many cancer-relevant functions, such as proliferation, migration, EMT, angiogenesis, MMP
production etc., are mediated in an isoform- and tissue-specific way (see Appendix, Table
A.1). Moreover, some studies show, that individual isoforms may play contradictory roles by
mediating different signaling pathways in carcinogenesis and metastasis [152, 155, 156]. For
example, PKD1 is downregulated in highly invasive prostate cancer, and when overexpressed,
blocks proliferation and migration by E-cadherin phosphorylation and activating the ERK
pathway [157, 158]. In contrast, PKD2 and 3 isoforms are upregulated and promote prostate
cancer cell invasion through several recently identified pathways [154, 159, 160]. Findings
regarding the role of each of the isoform in different cancer types are summarized in Table
A.1 (see Appendix). Pancreatic cancer was excluded from this table as it will be discussed
separately in more detail in the next chapter. The role of PKDs in cancer development is not
so straightforward and strongly depends on cell type, activation state and expression level.
Overall, the majority of research done so far shows that PKD1 has more anti-tumorigenic
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functions by inhibiting cell motility of various cancers [152, 153, 155, 158]. Moreover,
many malignant cells have reduced PKD1 expression [142, 156, 161, 162]. However, some
studies report also pro-invasive functions of PKD1 [163–166]. PKD2 and PKD3 isoforms
mediate more-uniformly pro-tumorigenic signaling pathways, such as upregulation of MMPs,
inducing drug resistance, excessive tumor proliferation and invasion [154, 159, 167]. In some
cancer types PKD2 and 3 isoforms have redundant, overlapping functions [154].
3.6 Role of PKD isoforms in pancreatic cancer progression
and pancreatic ductal adenocarcinoma
Recent studies in mice revealed a crucial pro-oncogenic role of PKD1 in early PDAC develop-
ment. In studies done by the Peter Storz’s group and collaborators, 2 different PKD1-facilitated
pathways (mutant KRAS/ROS/PKD1/NF-κB/EGFR and TGFα/KRAS/PKD1/Notch) were
identified for acinar dedifferentiation, ADM transition and further progression into PanIN
precancerous neoplasia [143, 168]. In both studies it was shown that PKD1 is activated down-
stream of either activated or mutant KRAS and conditional knockdown of PKD1 decreased
the progression of ADM and PanIN. The role of PKD2 and PKD3 isoforms was not discussed
in this context.
In vitro research sheds more light on individual isoform expression levels and functions in
the highly invasive pancreatic cancer cell lines. PKD1 and PKD2 protein expression levels,
compared to healthy cells, have been shown to be elevated in Panc1 and Panc89 cell lines
[169]. PKD3 expression was not changed in all the cell lines analyzed. Eiseler et al. have
demonstrated PKD1-driven proliferation and anchorage-independent PDAC growth mediated
by Snail1 phosphorylation (transcription factor, which can trigger EMT) [170]. In a different
study, the authors demonstrated anti-invasive/antimigratory properties of PKD1 through its
control of F-actin polymerization. Cortactin and cofilin-phosphatase Slingshot1L (SSH1L),
proteins which control F-actin polymerization and depolymerization, were identified as PKD1
substrates [142, 155]. PKD1 inhibition resulted in higher motility of cancer cells, hence
promoting invasive behavior of pancreatic cancer, whereas overexpression of this isoform
inhibited migration and invasiveness [155, 169]. The authors argued that presence of PKD1
at early stages of PDAC development is beneficiary for tumor progression, whereas the
downregulation at later stages would promote invasion. The seemingly dual role of PKD1 at
different stages of tumor progression is likely a direct result of its diverse array of substrates.
On the contrary, the data regarding PKD2 isoform involvement shows uniformly proinvasive
quality in pancreatic cancer. Meta-analysis of different pancreatic cancer tissues showed that
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PKD2 mRNA expression levels were significantly higher in comparison with control tissues
and also in comparison with PKD1 mRNA [169, 171, 172]. PKD2 expressing pancreatic
cancer cells have∼ 11-fold time higher concentration of matrix metalloproteinases (especially
MMP7 and MMP9) [169]. By regulating expression levels of MMP7/9, PKD2 mediates cancer
cell invasiveness not only through ECM degradation, but also by regulating angiogenesis,
as MMP7/9 actively contribute to angiogenesis [169, 173, 174]. The opposing functions
of PKD1 and PKD2 make it clear that in order to successfully use them in therapy isoform
specific inhibitors have to be developed. Less is known about the role of PKD3 in pancreatic
cancer.
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Chapter 4
Objectives
The goal of the presented thesis was to study two biophysical aspects of single cell migration,
a complex process essential to health and disease.
In the first part of the thesis project, presented in Chapters 6 and 7, the effects of temperature
and temperature gradients on immune cell motility was investigated. Temperature varies
on different length scales form subcellular size to tissue, organ or human body dimension.
Knowing how sensitive cells are to any biophysical and biochemical alterations in the ex-
tracellular environment, it is surprising that not many studies have investigated the effect of
thermal variations on basic cell functions like migration. For example, as part of the body’s
immune system, leukocytes are required to navigate through various tissues with alternating
temperatures in order to successfully migrate towards an injured or infected site. In this
regard, one specific aim of the presented work was to elucidate the effect of extracellular
thermal changes on immune cell motility. Using differentiated HL-60 cells, a model cell
line for blood neutrophils (the fastest human cells and the first responders to infection), 2D
cell migration was studied at physiologically relevant temperature ranges of 27 to 43 ◦C.
The migration experiments were carried out both by stepwise increasing the temperature by
small increments and using temperature gradients. Therefore, a temperature gradient chamber
was developed. Additionally, based on the ability of blood neutrophils to form autonomous
motile cell fragments when heat-treated for short periods of time, cell fragment formation
was attempted using differentiated HL-60 cells.
Not only external signals such as temperature affect cell motility but also cancer-associated
changes of internal signaling can alter cell migration and responses to external signals.
Therefore, in the second part of the thesis project, presented in Chapters 8 and 9, pancreatic
cancer cell lines with Crispr/Cas9 PKD1, PKD2 and PKD3 knockouts were used for the first
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time to study in vitro the Protein Kinase D isoform-dependent effects in cancer cell migration
associated with invasive behavior.
Protein Kinase D enzymes, a family of three structural isoforms called PKD1, PKD2 and
PKD3, have been shown to play a significant regulatory role in cancer motility and invasion
but lack of methods to address each isoform specifically limited research. Stable isoform-
selective Crispr/Cas9 knockouts, done by a collaboration partner, allowed for controlled
deletion of each isoform, which gives an advantage over the previously used methods, such as
pan-PKD inhibition with chemicals, PKD isoform partial knockdown or ectopic introduction
of one or another isoform.
PKD1 KO, PKD2 KO and PKD3 KO pancreatic cancer cell migration and invasion was
studied to elucidate emerging changes in response and migration to the loss of each isoform.
Towards this aim, various biophysical in vitro migration assays were implemented, starting
from cell migration studies on basic glass surfaces, followed by more complex PDMS-based
surfaces with microgrooved structures capable of contact guidance induction. Additionally,
PKD isoform-selective and MMP-independent pancreatic cancer cell invasion studies were
performed using PDMS-based migration chips with precise microchannel architecture. In
order to link the altered invasion-associated behavior to mechanical properties, a further aim
of this thesis was to characterize the KO cells in this respect.
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Materials and Methods
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Chapter 5
Materials and Methods
5.1 Fabrication of migration assays
In this work different in vitro migration assays were used to study cell motility in 2D and
3D. Basic 2D migration studies were performed on commercially available glass-bottom
petri dishes. Custom temperature gradient chambers were developed and manufactured for
differentiated HL-60 cell thermotaxis studies. PDMS-based (Polydimethylsiloxane) substrates
and microchips used in pancreatic cancer cell studies were fabricated based on the methods
previously developed in our group [36, 175, 176].
5.1.1 Temperature gradient chamber fabrication for 2D and 3D exper-
iments
Temperature gradient chambers were manufactured based on a modification of the system de-
scribed in Das et al. [177], using ridged Plexiglas molds with ridge dimensions of 8.0x2.0x0.2
mm3 (L:W:H) for 2D experiments and 8.0x2.0x8.0 mm 3 (L:W:H) for 3D experiments
(Figs. 5.1 A and B, respectively). As a heat source and heat sink, rectangular hollow copper
reservoirs 18x6x8 mm3 (L:W:H) were used with inlets and outlets to supply heated and chilled
water. These were attached to the mold with screws parallel to the microridge. 1:10 PDMS
184 (#2699150, Dow Corning, United States) was poured in the mold and subsequently cured
at 65 ◦C overnight. To be able to inject cells into the 2D PDMS microchambers, two holes
with 1 mm diameter were punched into the PDMS. The PDMS chips were bound to a glass
coverslip via oxygen plasma treatment (30 seconds at 0.7 mbar oxygen pressure and 200 W
power, Plasma System 100, PVA TePLa) of both the glass and the PDMS, followed by an
overnight thermal treatment at 65 ◦C. The copper reservoirs were then detached from the mold
and inserted into the PDMS microchamber. The assembled temperature gradient chambers
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Figure 5.1: Schematic representation of the microfluidic 2D (A) and 3D (B) temperature gradi-
ent chambers with cross sections in X and Y directions. Copper reservoirs were used as a heat
source and a heat sink, with their temperatures held constant at 65 ◦C and 5 ◦C, respectively.
were then sterilized for two hours under UV light. In order to assess the temperature gradient
applied to the cells, Comsol Multiphysics 5.1 3D simulations were performed for the geometry
used in the experimental setup (Comsol Inc, Sweden). Heat Transfer in Solids mode was
applied for the analysis. Several assumptions were made to simplify the computation:
• The liquid in the microchannel is considered to be water, not biological media.
• The copper reservoirs were considered to be solid blocks with a constant temperature
corresponding to the temperature used during experiments (65 ◦C for the heat source
and 5 ◦C for the heat sink).
• The external boundaries of the device were assumed to exchange heat by natural
convection only. The ambient temperature and pressure were set to 37 ◦C and 1 atm.
Computations performed using COMSOL Multiphysics showed a uniform temperature gradi-
ent along the whole microchamber with a range from 27 ◦C to 43 ◦C (Fig 5.2).
5.1.2 PDMS-based microgrooved substrate and invasion chip fabrica-
tion and functionalization
Both microgrooved substrates and microchannel invasion chips were fabricated by replica
molding of 1:10 PDMS on silicon (Si) wafers with the desired structures. The microstructured
silicon wafers were fabricated using photolithography-based protocols previously developed
in our group [36, 175, 176]. Briefly, photoresist coated Si wafers (Siegert Wafer GmbH,
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Figure 5.2: 3D Volume temperature gradient distribution computed by COMSOL Multiphysics.
A 27-43 ◦C temperature gradient is generated along the 2 mm wide microchannel.
Germany) were aligned to Chromium photomasks (ML&C GmbH, Germany) with the desired
structures. The wafers were then irradiated with UV light (λ = 405nm) from a mercury
lamp source (HBO 350 W, Osram, Germany). Following UV exposure, the structured wafers
were developed and baked. For microgrooved substrates, the microstructured silicone wafers
were coated with chromium of desired thickness by using physical vapor deposition. After a
washing step necessary for photoresist removal, the wafers were placed in petri dishes to be
used as molds. For invasion chips with microchannel structures, a two-step photolithography
technique with two different photomasks was used to achieve the desired structures.
Microgrooved substrates with 2 and 10 µm wide and 200 and 350 nm deep grooves (Fig. 5.3A)
were prepared by replica molding of PDMS in the microgrooved Si molds. 1:10 PDMS
mixture of curing agent and polymer base (w/w) were poured into the molds, followed by a
4-hour curing step at 65 ◦C. The cured PDMS elastomers were then peeled off and placed
in 6-well plates (#657160, Greiner Bio-One, Frickenhausen, Germany). After subsequent
washing steps with 70 % ethanol (#K928.3, Roth, Germany) and sterile 1x DPBS (Dulbecco’s
Phosphate-Buffered Saline, #14080-048, Gibco, Germany), the substrates were functionalized
by a 1-hour long incubation with 10 µg/mL bovine Fibronectin (bFN) (#86088-83-7, Sigma
Aldrich, Germany) in PBS. After a final washing step with cell media, the substrates were
ready for cell seeding.
Invasion chips with two different microchannel dimensions (WxHxL 3x11x150 µm3 and
10x11x150 µm3) were prepared by PDMS replica molding as described above. Each chip
contained 80 microchannels for each dimension. To create enclosed microchips (Fig. 5.3 B)
the PDMS replica were bound to glass coverslips via oxygen plasma treatment of both the
CHAPTER 5. MATERIALS AND METHODS 30
Figure 5.3: Schematic representation of PDMS-based microgrooved substrates (A) and invasion
chips with microchannels (B) used for pancreatic cancer cell migration studies.
glass and the PDMS (25 seconds at 0.7 mbar oxygen pressure and 200 W power), followed by
a 30-minute thermal treatment at 80 ◦C. The invasion chips were then incubated overnight at
4 ◦C with 100 µg/mL Collagen I (#A10483-01, Gibco) solution in PBS. After a washing step
with sterile PBS, the chips were exposed to one hour of UV light for sterilization purposes.
After a final washing step with cell media the microchips were ready to be seeded.
5.2 Cell biology methods
5.2.1 Cell Culture
5.2.1.1 HL-60 cell culture and differentiation
HL-60 cells were obtained from Deutsche Sammlung von Mikroorganismen und Zellkulturen
(DSMZ, Germany) and kept in cell culture at a maximum concentration of 106 cells per millil-
itre. For differentiation purposes, cells (passage numbers 6-9) were cultured with an initial
concentration of 105 cells per millilitre in the presence of 1.3 % DMSO (Dimethyl Sulfoxide,
#D2650, Sigma Aldrich) in cell culture media (RPMI 1640 + GlutaMax, #61870, Gibco)
supplemented with 10 % heat inactivated fetal bovine serum (FBS) (#10500, Gibco) and 1
% Penicillin-Streptomycin antibiotics (#15140, Gibco). On Day 2, cells were centrifuged,
counted, and cultured again in presence of 1.3 % DMSO with a cell concentration of 105
cells per millilitre. On Day 4 the media was changed. On Days 5-7 cells were sufficiently
differentiated and could be used for experiments.
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5.2.1.2 3-D cell culture for temperature gradient studies
Differentiated HL-60 cells were cultured in Collagen I hydrogel scaffolds as described by
Shin et al. [178]. Briefly, 20 µL of 10x DPBS (#14080, Gibco) was thoroughly mixed with
11 µL of 0.5 N NaOH solution (#1.06498.0500, Merck, United States), 133 µL of 3 mg/mL
rat tail Collagen I stock solution (#A10483, Gibco) and 36 µL of cell suspension (200,000
cells overall) for a final concentration of 2.0 mg/mL collagen. All ingredients and vials were
precooled and hydrogel solution preparation was performed on ice.
5.2.1.3 Neutrophil isolation
Human blood neutrophils were isolated from fresh venous blood of two donors. Heparin-
Calcium (Ratiopharm, Ulm, Germany) was used as an anticoagulant. Fresh blood was left to
sediment at an angle of 45◦ for two hours. The middle layer, containing white blood cells, was
then pipetted, suspended in DPBS without Ca2+ and Mg2+ ions (#D8537, Sigma Aldrich),
and centrifuged gently. After centrifugation, the cells were re-suspended in human blood
plasma.
5.2.1.4 Pancreatic cancer cell culture
PKD1, PKD2, PKD3 Crispr/Cas9 knockout Panc1 (PKD1 KO, PKD2 KO, PKD3 KO, re-
spectively) and wild type Panc1 pancreatic cancer cell lines were kindly provided by Dr. Tim
Eiseler from Dr. Thomas Seuferlein’s laboratory at University Clinic Ulm. The cells were
cultured in Dulbecco’s Modified Eagle Medium (DMEM) (#31966, Gibco) with the addition
of 10 % FBS and 1 % Penicillin-Streptomycin. The cells were passaged when at 80-90 % cell
confluence using pre-warmed 0.25 % Trypsin/EDTA (#25200, Gibco). Following inhibition
of trypsin with DMEM+10 % FBS (twice the amount of Trypsin used), the cell suspension
was centrifuged at 600 rpm for 5 minutes. After resuspending the cell pellet in fresh growth
media, the cells were counted using a Neubauer chamber for cell seeding for the experiments.
5.2.2 Immunocytochemistry
5.2.2.1 Giemsa-Wright staining of differentiated and non-differentiated HL-60 cells
Giemsa-Wright staining was performed according to the manufacturer’s instructions (#WS16,
#GS500, Sigma Aldrich). Briefly, 105 cells in 300 µL media were spun onto a Cytospin slide
and subsequently fixed with methanol for 15 minutes. After drying, slides were incubated with
500 µL of Wright solution for 2 minutes, rinsed with dH2O and incubated with a 1:20 Giemsa
solution diluted with dH2O for one hour. Afterwards, the slides were thoroughly washed
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with dH2O and dried. Imaging was performed using a Zeiss Axiovert200M microscope, a
Plan-Apochromat 63x oil objective (Zeiss) and an AxioCam IC camera (Zeiss).
5.2.2.2 Pancreatic cancer cells
Filamentous Actin (F-actin), nuclei, focal adhesion (FA) protein vinculin and cell-cell adhe-
sion molecule E-cadherin of fixed PKD1 KO, PKD2 KO, PKD3 KO and Panc1 control cells
seeded on a glass surface were fluorescently labeled and imaged using confocal fluorescence
microscopy. Cells were seeded in 6-well glass-bottomed petri dishes (#P06-1.5H-N, In Vitro
Scientific, United States), incubated overnight at 37 ◦C and 5 % CO2 and fixed with 3.7 %
Parafomaldehyde (PFA) (Sigma Aldrich) in PBS for 15 minutes at 37 ◦C, followed by cell
membrane permeabilization with 0.1 % Triton X-100 (#93421, Fluka, Germany) in PBS for
15 minutes at room temperature. After thorough washing step with PBS, antibody unspecific
binding sites were blocked by treating the cells with 5 % bovine serum albumin (BSA)
(#9048-46-5, Sigma Aldrich) for one hour at room temperature, following another one hour
incubation with primary antibodies solution in 5 % BSA at 37 ◦C. Afterwards, the cells were
rinsed again with PBS and incubated with secondary antibody solution in 5 % BSA for 30
minutes at room temperature. After a final washing step with PBS, the cells were ready for
imaging. The list of the primary and secondary antibodies and the concentrations used is
given in Table 5.1.
Table 5.1: List of antibodies used for modified and non-modified Panc1 cells staining
Primary antibody, dilution factor Secondary antibody, dilution factor
F- actin N/A
Alexa Fluor 568 Phalloidin (#A12380, Life
Tech., Germany), 1:500
Nuclei N/A
Hoechst 33342 (#H3570, Life Tech.,
Germany), 1:5000
Vinculin
Mouse anti-Vinculin (#V9131, Sigma
Aldrich), 1:400
Goat anti-Mouse488 (#A-11029, Life
Tech.), 1:500
E-cadherin
Mouse anti-E-cadherin (#610182, BD
transduction lab), 1:25
Goat anti-Mouse488 (#A-11029, Life
Tech.), 1:500
Imaging was carried out using an inverted confocal Laser-Scanning-Microscope (SP5, Leica
Germany) equipped with an argon and a white light laser (WLL). Images were acquired
using a 63x oil-immersion objective (HCX PL APO 63x/1.40-0.60; Leica Microsystems
GmbH, Germany). The pinhole for data acquisition was set to 1 Airy unit. Fluorophores
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were excited at 350, 488 and 558 nm and the detection windows were set at 380-450 nm,
500-540 nm and 568-610 nm, respectively. 10 to 15 images (0.99 µm apart) in z direction
were acquired. Images were processed with Fiji software [179]. Using the Z project function
of the software, z-stack images were projected into one image. Maximum Intensity projection
type was applied. Brightness and contrast of the images was then modified for each image.
5.2.3 Cell seeding, cell imaging and image analysis: Differentiated HL-
60 cells
5.2.3.1 2D glass surfaces
Cell seeding: Differentiated HL-60 cells (Days 5-7) were centrifuged at 1000x g for 5 minutes,
the supernatant was removed, and the cells were resuspended in corresponding RPMI-1640
media not containing DMSO. 200,000-1,000,000 cells in 250 µm media were placed in
sterile 20 mm or 35 mm glass-bottom petri dishes (#627860, Greiner Bio-One, Germany)
and incubated for one hour at 37 ◦C and 5 % CO2. Afterwards, in order to remove as many
non-adherent cells as possible, media was aspirated and the petri dishes were washed three
times. After addition of 2 mL of fresh pre-heated (37 ◦C ) media, the petri dishes were placed
on a heating plate and time-lapse movies were generated.
Three different seeding conditions were used for experiments with static temperatures: control,
bovine fibronectin (bFN) glass coating, and 5X FBS. Cells seeded on the glass surface of the
petri dish without any coating and with media containing 10 % FBS was used as a control.
For bFN experiments, the petri dish was incubated with 100 µg/mL bFN (Gibco) for two
hours at room temperature and subsequently washed with PBS three times for 5 minutes each.
Afterwards, they were filled with media containing 10 % FBS and stored until cell seeding.
For the third seeding condition, a 5-fold increase of FBS in the media compared to the control
was used for the duration of the experiment.
Cell imaging: After cell seeding, samples were placed on a transparent thermoplate (Tokai
Hit, Model TP-KI05-60, Thermofisher, Darmstadt, Germany), which was then placed on the
stage of an Axiovert200M microscope. Time-lapse movies were taken with a 10x objective
(EC Plan-Neofluar, Zeiss) every 10 seconds. Cells were heated from 30 ◦C to 42 ◦C. During
this process, the temperature was held at 30 ◦C, 33 ◦C, and 35 ◦C for one hour each and at
37 ◦C for 30 minutes. Starting with 37 ◦C, the temperature was changed every 10 minutes
by 0.5 ◦C until a final temperature of 42 ◦C. The temperature change of the plate caused
thermal expansion, which resulted in gradual defocusing of the images. To address this,
imaging was shortly paused at 39 ◦C for focus adjustment.
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Image analysis: To assess cell attachment at different seeding conditions and temperatures,
the number of attached and floating cells in 10 positions (each with an area of 0.6 mm2) from
two independent experiments was counted and averaged.
To investigate the effects of temperature on cell velocity, for each condition and each tem-
perature, 39-78 cells were manually tracked for 8 minutes (50 frames) using Fiji’s Manual
CellTracker plug-in [179]. At 39 ◦C and 40 ◦C on bFN coating, 117 cells were tracked.
For the lower temperatures (30 ◦C to 37 ◦C), videos taken from the last 10 minutes of each
corresponding temperature were analyzed. The instantaneous speed of each cell was then
calculated and averaged. The mean speed results presented in this work are averaged from the
number of cells tracked for each specific condition at a given temperature.
To evaluate differentiated HL-60 cell persistence at different temperatures, autocorrelation
analysis was performed on the tracked data of the cells. Autocorrelation was computed
over 1/3 of the track length for each condition and temperature using the DiPer macro
provided by Gorelik et al. [24]. Exponential fitting of the autocorrelation data was done in
MATLAB R2016a using the following equation:
αe−t/τ + c , (5.1)
where τ is the persistence time. The average persistence length was then calculated by
multiplying the persistence time by the average speed at each temperature.
5.2.3.2 Temperature gradient studies
The temperature gradient was initiated by supplying hot and cold water to the copper reservoirs
being continuously exchanged through two peristaltic pumps. The temperature of the supplied
water was kept constant via a heating plate and an ice bath. A thermocouple was attached
to each copper reservoir to monitor the temperature of the reservoirs for the duration of the
experiments.
2D experiments were performed by injecting cells into the microchamber at a concentration
of 150 cells/mm2 and imaging every 15 seconds. Prior to temperature gradient initiation, cells
were imaged for 30 minutes at 37 ◦C. To achieve the desired temperature gradient range of
27 ◦C to 43 ◦C, the hot and cold sources were supplied with 65 ◦C and 5 ◦C water, respectively.
After gradient initiation, cells were imaged for 40 minutes. 50 cells in total were tracked. The
mean cell speed was then calculated as described above.
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To investigate cell behavior in 3D temperature gradients, 50 µL of collagen I gel solution
containing 2x105 cells was loaded into the 3D cell reservoir. To promote collagen gelation,
gradient chips were incubated for 50 minutes at 37 ◦C and 5 % CO2. Afterwards, the cell
reservoir was covered with a glass coverslip and sealed from all sides using addition-curing
silicone (Picodent twinsil® speed, Wipperfürth, Germany). Cells were then imaged via phase
contrast every 5 minutes with a 10x objective. Multiple 2D planes were acquired throughout
the 3D collagen scaffold at a z-spacing of 20 µm. Prior to initiation of the temperature
gradient, cells were imaged for one hour at 37 ◦C. After initiation, cells were imaged for
eight hours. 20 cells in total were tracked in 20 different z planes. Mean cell speed was then
calculated as described above.
5.2.3.3 Shear flow assay
Channel slides with dimensions of 50 x 5 x 0.2 mm3 (LxWxH) (Ibidi GmbH, Germany)
were used to investigate differentiated HL-60 cell behavior under shear flow. The flow rate,
controlled by syringe pumps (Pump11Elite, Harvard Apparaturs, USA), was kept at either
30 µL/hour or 40 µL/hour. Media was injected with 1 mL syringes (Omnifix®-F, B.Braun,
Germany) connected by a cannula (Sterican®, 0.4 x 20 mm2, BL/LB, B.Braun, Germany)
and PTFE-tubing (0.4 x 0.9 mm2, Bola, Germany). The cells were kept under constant
flow for one hour and imaged at a 1-minute interval. For each of the two flow conditions,
two independent experiments were performed. In total, 50 cells from at least five different
chamber positions were tracked.
5.2.4 Cell seeding, cell imaging and image analysis: Blood neutrophils
Freshly isolated blood neutrophils, suspended in blood plasma, were seeded on glass-bottomed
petri dishes and left for 10 minutes at 37 ◦C and 5 % CO2 to ensure neutrophil attachment.
After gentle washing with preheated blood plasma, the samples were placed on a transparent
thermoplate (Tokai Hit, Model TP-KI05-60, Thermofisher, Darmstadt, Germany), which was
then placed on the stage of an Axiovert200M microscope. Time-lapse movies were taken with
a 40x air objective (LD Plan-Neofluar, Zeiss) every 5 seconds. Cells were imaged at 37 ◦C
for 10 minutes, followed by a 10-minute long heating step at 45-47 ◦C, necessary for cell
fragment formation (also known as citokineplasts). Afterwards, the temperature was cycled
back to 37 ◦C and the cells were imaged for another 10 minutes. Blood Neutrophil velocity
was assessed at 37 ◦C by manually tracking 20 cells isolated from two donors using Fiji’s
Manual CellTracker plug-in [179]. The instantaneous speed of each cell was then calculated
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and averaged. The mean speed results presented in this work are averaged from the number
of cells tracked.
5.2.5 Cell seeding, cell imaging and image analysis: Pancreatic cancer
cells
5.2.5.1 2D glass surfaces
Cell seeding: PKD1 KO, PKD2 KO, PKD3 KO and Panc1 control cells were seeded at a
concentration of approximately 30 cells/mm2 on commercially available glass-bottom petri
dishes (Greiner Bio-One). All experiments were carried out 24 hours after the initial seeding
to ensure full cell attachment and spreading.
Cell imaging: For cell attachment, proliferation and morphological studies phase contrast
images were taken 24 hours after cell seeding at 10 separate positions for each sample.
For cell migration studies, phase-contrast imaging was performed in a heated chamber (37 ◦C
and 5 % CO2) of an inverted AxioObserver (Zeiss) microscope equipped with a halogen lamp
(Hal 100). Time-lapse movies were taken with a 10x objective (LD Plan-Neofluar, Zeiss)
every 5 minutes over a 24-hour period.
Image analysis: To assess cell attachment efficiency of Panc1 cells in the absence of each
PKD isoform, the number of attached cells in 20 positions (each with area of 0.6 mm2) from
two independent experiments was counted 24 hours after cell seeding. The rounded cells
were considered to be non-adherent. Cell attachment efficiency was then calculated as:
Attachment E f f iciency(%) =
(
Cell No at 24h
Cell No at seeding
)
∗100 . (5.2)
After 72 hours the cells were passaged and the total number of cells was estimated by using
flow cytometer. The proliferation rates of each cell line were expressed as:
Cell Proli f eration =
Cell No at 72h
Cell No at 24h
. (5.3)
To assess pancreatic cancer cell velocity for each knockout and control 45-50 cells were man-
ually tracked for 24 hours using Fiji’s Manual CellTracker plug-in [179]. The instantaneous
speed of each cell was calculated and averaged. The mean speed results presented in this
work are averaged from the number of cells tracked. Three independent experiments were
performed. For morphological studies, 30 cells for each cell line were manually outlined in
Fiji. Using the Measure function in Fiji, cell area and cell aspect ratio (AR) were measured.
AR is defined in more details in section 5.2.5.2.
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To evaluate cell persistence, mean square displacement (MSD) analysis was performed on the
tracked data of the cells (see Introduction, Section 1.2). MSD was computed over 1/6 of the
track length (four hours) for each condition using the DiPer macro provided by Gorelik et
al. [24]. Obtained MSD curves were fitted with persistent random walk model (PRW) in
MATLAB R2016a using the following equation:
MSD(t) = 2S2Pt
(
t−Pt
(
1− e−t/Pt
))
, (5.4)
where Pt is the persistence time and S is the cell speed. Time dependent changes of MSD
follow a power law MSD ∝ tβ , where β is a dimensionless number between 0 and 2, indicating
different migration modes. β(t) was obtained from the logarithmic derivative of MSD curves:
β (t) =
d (ln MSD(t))
d (ln t)
. (5.5)
5.2.5.2 PDMS-based microgrooved substrates
Cell seeding: PKD1 KO, PKD2 KO, PKD3 KO and Panc1 control cells were seeded at a
concentration of approximately 30 cells/mm2 on bFN-coated microgrooved PDMS substrates.
All experiments were carried out 24 hours after the initial seeding to ensure full cell attachment
and spreading.
Cell imaging: For cell migration studies, phase-contrast imaging was performed in a heated
chamber (37 ◦C and 5 % CO2) of an inverted AxioObserver (Zeiss) microscope equipped
with a halogen lamp (Hal 100). Time-lapse movies were taken with a 10x objective (LD
Plan-Neofluar, Zeiss) every 10 minutes over a 20-hour period.
Image analysis: Morphological studies and cell alignment of the grooves was carried out by
manually outlining 30-50 cells (from two independent experiments) on each groove dimension
24 hours after seeding. Cell aspect ratio and orientation parameter were then measured by
fitting an ellipse to the cell outlines as shown in Figure 5.4. The AR is then defined as:
AR =
ama jor
aminor
, (5.6)
where ama jor and aminor are major and minor axes of the best fitting ellipse of the cell outline.
Cell alignment on the grooves is given by cell orientation parameter S averaged over all cells:
S =
1
n∑cos(2θ) , (5.7)
where n is the number of the cells and θ represents the angle in radians between major axis
of the fitted ellipse and the groove direction, here x-axis (Fig. 5.4). S is a dimensionless
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parameter with values ranging from -1 to 1, with S = 1 denoting perfect, S = 0 random and
S = -1 perpendicular alignments.
Figure 5.4: Best fitting ellipse of a cell on a microgrooved substrate used for cell AR and align-
ment analysis.
To assess pancreatic cancer cell velocity for each cell line and groove dimension 30-50 cells
were manually tracked for 20 hours using Fiji’s Manual CellTracker plug-in [179]. The
instantaneous speed of each cell was then calculated and averaged. The mean speed results
presented in this work are averaged from the number of cells tracked. Migration displacement
angles with respect to the groove direction were also calculated from cell migration vectors.
Steps smaller than 3 µm were disregarded.
5.2.5.3 PDMS-based microchannel invasion assay
Cell seeding: PKD1 KO, PKD2 KO, PKD3 KO and Panc1 control cell suspensions, containing
approximately 40x103 cells in 80 µL media, were injected into the cell inlet of collagen-
coated invasion microchips (Fig. 5.3 B). Cell reservoirs located opposite of the cell inlet were
filled with cell culture media. After one hour incubation at 37 ◦C and 5 % CO2, the petri
dish containing the chips was filled with 2 mL cell media to ensure sufficient nutrition for
long-term experiments. All experiments were carried out 24 hours after the initial seeding to
ensure full cell attachment and spreading.
Cell imaging: Life phase-contrast imaging was performed in a heated chamber (37 ◦C and
5 % CO2) of an inverted AxioObserver (Zeiss) microscope equipped with a halogen lamp
(Hal 100). Time-lapse movies were taken with a 10x objective (LD Plan-Neofluar, Zeiss)
every 10 minutes over a 48-hour period.
Image analysis: Image processing was performed in Fiji. Single cell-channel interactions
were divided into three categories: Penetration, invasion and permeation (Fig. 5.5). Cells
that partially extended into the channels (up to 50 % of the channel length), without fully
entering them, were classified as penetrating cells. Cells that completely entered or penetrated
39 CHAPTER 5. MATERIALS AND METHODS
≥ 50 % without leaving the channels from the opposite side were considered invasive cells.
And lastly, the cells that completely migrated through the channels were termed permeative.
Figure 5.5: Three categories of cell-channel interactions.
To evaluate average migration speed of permeating cells, the leading edge of the cells was
tracked using Fiji’s Manual CellTracker plug-in [179]. The tracking was stopped as soon as
the front of the cells reached the opposite edges of the channel. Cells undergoing mitosis
inside the channels were excluded from this analysis. The instantaneous speed of each cell
was then calculated and averaged. The mean speed results presented in this work are averaged
from the number of cells tracked. Three independent experiments were performed.
5.3 3-D optical stretching of pancreatic cancer cells
To estimate PKD-isoform dependent changes in mechanical properties of Panc1 cancer cell
line, a 3D optical stretcher was used (RS Zelltechnik, Germany). The optical stretcher is a
dual laser tool that was first introduced by Guck et al. [180], that uses light force to trap
and deform small biological objects, such as cells and lipid vesicles. The working principle
of the optical stretcher is based on momentum transfer from the light to the object, which
results in forces exerted on the object. As a ray of light hits the cell, changes of photon
momentum occur due to differences in refractive indices of the surrounding media and cell.
The conservation of momentum leads to forces acting perpendicular to the cell surface. Using
two identical, counterpropagating laser beams allows for a symmetric stretching of the cells
along the laser beam axis (Fig. 5.6A).
The setup of the 3D optical stretcher consists of an optical measurement chamber mounted
on an inverted microscope (AxioImager, with a 63x air objective, LD Plan-Neofluor, Zeiss)
equipped with a high-resolution camera (Zyla 5.5 sCMOS, Andor Technology-Oxford Instru-
ments, Northern Ireland). Inside the measurement chamber a glass capillary, which serves as
cell flow channel, is situated between two optical fibers (Fig. 5.6B). 1064 nm laser (Fibolux,
FIBOTEC, Germany) with two separately controllable outputs and a maximum power of
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Figure 5.6: Working principle of 3D optical stretcher. A. Forces exerted on the cell surface due to
momentum transfer lead to cell deformation along the beam axis. Image adapted from Lautenschläger
et al. [181]. B. Optical measurement chamber, consisting of a glass capillary situated between two
optical fibers. Image was adapted from RS Zelltechnick marketing material. C. Laser power profile
used in the measurements. The cells, supplied into the capillary with a microfluidic pump, were
trapped at low (100 mW) and stretched at higher (1000 mW) laser powers. 1064 nm laser was used as
a light source. D. Phase contrast images of a representative cell being optically trapped (t = 0s) (i) and
stretched (t = 3s) (ii). The black and the red lines represent the cell boundaries, with a0, b0 and as, bs
being the semi-axes of trapped and stretched cell, respectively. (iii) Overlap of trapped and stretched
cell outlines. Scale bars: 10 µm.
2 × 2 W attached to the chamber serves as light source. The microscope, with the mounted
measurement chamber, was situated in a housing with a temperature control system to ensure
stable temperature during measurements. The temperature was kept at 23 ◦C. The cell suspen-
sion, containing approximately 105, was supplied into the capillary using a microfluidic pump.
The flow rate was controlled automatically by the program provided by the manufacturer.
During object trapping and stretching the flow was stalled. The cells were trapped for 1 s
at low laser power of 100 mW, stretched for 2 s at 1000 mW, followed by a 2-second long
relaxation period at 100 mW (Fig. 5.6C). 30 images per second were obtained for each cell
throughout the measurement. The program was equipped with a cell-edge detection algorithm,
which allowed automatic and swift image processing. One important factor for automatic
image processing is the sharp white contrasting ring around the cell surface appearing in the
phase contrast images (Fig. 5.6.D). This is necessary for the algorithm to precisely detect
object shape by detecting the borders. Cell shape irregularities and bleb formation during
stretching would lead to inconsistent measurements.
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To quantify cell deformability, relative change in cell ellipticity was calculated for each cell:
Cell de f ormability =
((
as−bs
as
)
−
(
a0−b0
a0
))
∗100 , (5.8)
where a0, b0 and as, bs are the semi-axes of trapped and stretched cell, respectively (Fig. 5.6D).
The average deformability of each cell line at each time point was then estimated by averaging
over all the cells measured.
5.4 Statistics
Autocorrelation and MSD data is presented as mean ± SEM. All other data is presented as
mean ± 95 % confidence intervals (CIs). Statistical analysis was performed in GraphPad
Prism (San Diego, CA, USA). Significance was evaluated where applicable either by standard
unpaired one-way ANOVA, unpaired two-way ANOVA or by unpaired Welch’s t-test. The
normality of the t-test was assessed using the D’Agostino & Pearson normality test.
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Temperature-sensitive migration
dynamics in neutrophil
differentiated HL-60 cells
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Chapter 6
Results
In the study described in this chapter, differentiated HL-60 cells were used as a model cell line
to investigate temperature-dependent neutrophil migration. HL-60 cells are immortal human
blood promyelocytic leukemia cells capable of terminal differentiation into more mature
white blood cell types such as neutrophils or monocytes.
6.1 HL-60 cell differentiation
HL-60 cells were differentiated into neutrophil-like cells using 1.3 % DMSO. Differentiation
was induced for five to seven days, after which cells were resuspended in DMSO-free
media. To qualitatively confirm the success of the differentiation into neutrophil-like cells,
Giemsa-Wright staining was performed prior to and after the differentiation protocol. Prior to
induction, HL-60 cells had rounded nuclei typical of that cell line, whereas the majority of
differentiated cells exhibited multi-segmented nuclei characteristic of neutrophils (Fig. 6.1A).
Non-differentiated HL-60 cells are non-adherent and cultured in suspension. Further con-
firmation of successful differentiation was the presence of adherent cells: By the third day
of differentiation, cells adhering to the bottom of the culture flasks were observed. By the
seventh day post-induction, the number of adherent cells increased five-fold (Fig. 6.1B).
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Figure 6.1: Successful differentiation of HL-60 cells into neutrophil-like cells. A. Giemsa-Wright
staining of HL-60 cell nuclei before (left) and seven days after differentiation (right) (Scale bars: 50 µm
and 20 µm top and bottom row, respectively). The majority of differentiated HL-60 cells exhibit lobed
nuclei characteristic to blood PMN cells. B. 10x phase contrast images thee days and seven days after
the start of differentiation. The amount of attached cells increases up to 10-fold. Scale bars: 50 µm.
6.2 Heat induced formation of motile cell fragments
Malawista et al. have demonstrated the ability of human blood polymorphonuclear leukocytes
to separate the motile machinery from the cell body under short-termed (8 to 10 minutes)
heat treatment [21]. The authors reported that despite the uncoupling from cell body, the cell
protopods retained their ability to attach to surfaces and exhibit directed migration towards a
chemotactic signal both in vitro and in vivo [20, 67–69]. Despite this fascinating discovery
made already in 1982, very little has been done to date to understand the mechanism of the
uncoupling and to further study these motile fragments, named cytokineplasts (CKPs). This
is likely due to the drawbacks involved in working with blood neutrophils, as well as the
challenging procedure of fragment formation (see Introduction, Section 2.2).
In this work, CKP formation was attempted both in blood neutrophils and neutrophil differen-
tiated HL-60 cells. Blood neutrophils were isolated from fresh venous blood obtained from
willing donors (see Materials and Methods, Section 5.2.1.3).
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Figure 6.2: Motile fragment formation was possible in human blood neutrophils but not in
differentiated HL-60 cells. A. Representative phase contrast images of fully intact blood neutrophils
plated on glass slide at 37 ◦C (left), heated for 5 minutes at 47 ◦C (middle) and the formed CKPs at
37 ◦C (right). When heated to 45-47 ◦C, the cell protopods (green triangles) migrated away from the
cell body (red triangle). The motile cell fragments stayed attached to the cell body through a thin
filament. If the heating temperature and time were sufficient, the fragments fully detached from the
bodies, forming CKPs (right image, green triangles). Scale bars: 50 µm and 20 µm top and bottom row,
respectively. B. Representative phase contrast images of neutrophil differentiated HL-60 cells at 37 ◦C.
Some of the cells exhibited extreme cell elongation already at 37 ◦C, with motile front and cell bodies
connected with a thin filament. Scale bar: 50 µm. C. Heating at 43 ◦C, the maximum temperatures at
which some cells stayed adherent, was not sufficient for CKP formation. Nucleus containing bodies
retracted towards the motile front and the cells reassemble without any visible damage to them. Scale
bars: 20 µm.
Blood neutrophils were plated on glass slides, sealed with a coverslip and placed on a heating
plate on the stage of a microscope. Phase contrast imaging was used to observe neutrophil
migration and CKP formation. After ten minute-long imaging at 37◦C, the heating stage was
set to 45-47 ◦C for another ten minutes. Afterwards, the temperature was cycled back to
37 ◦C and the samples were imaged (Fig. 6.2A).
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In general, the number of motile neutrophils, their fragment formation and full decoupling (i.e.
exact temperature and heating period) highly depended on the donor. Only the fast migrating
cells formed CKPs. Upon heating, the motile fronts of the cells moved away from the cell body
staying attached to it with a thin filament (Fig. 6.2A). Longer heating periods (9-10 minutes)
led to the full decoupling of the motile fragments. If stored at 4 ◦C, the CKPs were motile
after 24 hours. As CKP formation from blood cells was extremely heterogeneous, the same
procedure was performed using neutrophil differentiated HL-60 cells, a model cell line used
for neutrophil studies. Extended motile protopods connected to cell body with a thin filament
were observed in this cell line already at 37 ◦C (Fig. 6.2B). However, heating neutrophil-like
HL-60 cells did not lead to fragment formation. Poor adherence of differentiated HL-60 cell
at temperatures higher than 40 ◦C was one of the biggest obstacles (Fig. 6.3). As described in
the next section, already at 43 ◦C most of the cells were detached. Regardless of temperature
applied, the extended motile front of the model cell line stayed adherent to the cell body.
After a period of some minutes the cell part containing the nucleus would detach from the
glass, retract towards the motile front and the cells would reassemble and continue movement
(Fig. 6.2C). Although differentiated HL-60 cells were not a successful neutrophil substitute
for CKP formation, they were further used to study cell migration under physiologically
relevant temperatures.
6.3 Temperature-dependent attachment and migration speed
in differentiated HL-60 cells.
Differentiated HL-60 cells were used to investigate neutrophil migration under the effect of
physiologically relevant temperatures (30-42 ◦C). Here, this thermal range is divided into 3
increments: hypothermic (30-35 ◦C), normal (35-39 ◦C), and hyperthermic (39-42 ◦C). Cells
were cultured on untreated glass bottom petri dishes and monitored migration monitored
using phase contrast microscopy. Differentiated HL-60 cells remained motile throughout
the entire temperature range applied (Fig. 6.3A). Elevated temperatures in the hyperthermic
range significantly reduced the amount of adherent cells. At 40 ◦C, approximately 50 % of
previously attached cells were observed floating in the media (Fig. 6.3Aiii). Detached cells
did not appear to be dead or apoptotic, as reduction of the temperature back to 37 ◦C resulted
in reattachment to the substrate (Fig. 6.3B).
To improve cell adhesion at higher temperatures, elevated serum concentration (5X FBS) and
a 100 µg/mL fibronectin (bFN) surface coating were both tested. Fibronectin coating did
not improve cell attachment in any of the temperature regimes (Fig. 6.4A). However, higher
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Figure 6.3: Representative phase contrast images of differentiated HL-60 cells at different heat-
ing conditions. A. Phase contrast images of control cell tracks at 30 ◦C (hypothermic), 37 ◦C (normal)
and 42 ◦C (hyperthermic). A large number of cells detached under hyperthermic conditions. Scale
bars: 100 µm. B. Phase contrast images of cells under control conditions at 37 ◦C, heated to 42 ◦C
and cooled back to 37 ◦C. Detached cells did not appear to be dead or apoptotic, as reduction of the
temperature back to 37 ◦C resulted in cell reattachment to the substrate. Scale bars: 200 µm.
serum concentration resulted in a 20-30 % increase in cell attachment for the entire range of
temperatures analyzed. The mean speed of differentiated HL-60 cells varied between different
conditions and as a function of temperature. For all three seeding conditions, the mean
migration speed increased nearly linearly with increasing temperature, with each increasing
degree Celsius causing a commensurate increase in cell speed of approximately 0.87 µm/min
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for control surfaces, 0.65 µm/min for 5X FBS, and 0.71 µm/min for fibronectin-coated
surfaces. No significant difference in mean speed was observed between cells cultured in
media containing 10 % FBS or 5X FBS. Fibronectin coating significantly reduced cell speed
(Fig. 6.4B).
Figure 6.4: Temperature-dependent attachment and migration dynamics of differentiated HL-
60 cells. A. Cell attachment at different seeding conditions. In control samples under hyperthermic
conditions, approximately 50 % of the initially attached cells detached. 100 µg/mL bovine fibronectin
(bFN) coating did not improve cell attachment compared to the control condition (no coating, 10 %
FBS), whereas a 5-fold increase in FBS (5X FBS) in the media resulted in a significantly higher
(20-30 %) number of attached cells throughout the entire (30-42 ◦C) temperature range. B. The average
cell speed ± 95 % CIs of differentiated HL-60 cells at each experimental temperature. Cell speed
increased linearly with increasing temperature for all conditions. Cells seeded in the presence of
5X FBS did not show any significant increase in average speed. 100 µg/mL bFN surface coating
significantly reduced average cell speed at normal and hyperthermic temperatures. 39 and 78 cells were
tracked for all conditions in hypothermic and normal/hyperthemic temperature ranges, respectively. At
39 and 40 ◦C on bFN coating, 117 cells were tracked. For all: N = 2 independent experiments were
performed. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001, N.S. not significant. Significance
was evaluated by two-way ANOVA.
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6.4 Temperature-dependent effects on differentiated HL-
60 cell directionality
Direction autocorrelation was calculated in differentiated HL-60 cells for 3 conditions and
9 temperatures using an algorithm published by Gorelik et al. [20, 67–69] (Figs. 6.5A-C).
This describes the correlation in migration path orientation over increasing time intervals.
Direction autocorrelation coefficients were computed by averaging the cosine of all angle
differences over increasing time intervals between two migration vectors that have been
normalized to the same length. These coefficients were then averaged for all cells tracked
over all pairs of time points and plotted against applied time intervals. The resulting curves
can be understood as follows: The steeper the decay of the plotted curves, the more frequently
the cells turn in different directions.
To quantitatively approximate the persistence length of the cells, autocorrelation curves were
fitted to Equation 5.1 (Materials and Methods) to yield the persistence time, which is the time
period below which directional orientation remains correlated. Average persistence length
was estimated by multiplying persistence time by the average speed at a given temperature.
The three seeding conditions did not affect cell average persistence length significantly at any
given temperature (Fig. 6.5D). While cells exhibit longer persistence lengths at hypothermic
temperature regimes, persistence length remained similar throughout normal and hyperthermic
regions. For all three surface coatings, cells cultured between 35 ◦C and 42 ◦C had consistent
persistence lengths between 9.8 and 14.9 µm.
To determine whether an increase in temperature was altering the fibronectin layer, an
experiment utilizing pre-heated fibronectin was performed. Fibronectin-coated glass was
heated for 1 hour at 41 ◦C. After cooling, differentiated HL-60 cells were seeded onto the
heat-treated fibronectin and time-lapse movies were taken at 37 ◦C for 1 hour. The heat
treatment of the coating significantly reduced average cell speed compared to non-treated
fibronectin (Fig. 6.5E). Interestingly, autocorrelation was not affected by fibronectin heat
treatment, further supporting the hypothesis that intrinsic cell persistence is not affected by
the ECM composition (Fig. 6.5F).
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Figure 6.5: Temperature- and ECM-dependent direction correlation of differentiated HL-60
cell migration. A-C. Direction autocorrelation analysis of differentiated HL-60 cells under 3 different
conditions (control, 5X FBS and bFN coating) and 9 different temperatures between 30 and 42 ◦C. At
hypothermic temperatures, directional autocorrelation peaks for all conditions. On bFN coating, cells
maintain directionality for longer time periods. Error bars represent S.E.M. D. Persistence length (µm)
of differentiated HL-60 cells was calculated by multiplying the persistence time by average cell speed.
The persistence time was evaluated by fitting equation 1 to the autocorrelation curves. At normal
and hypothermic conditions, the persistence length was preserved. Error bars represent 95 % CIs.
E. Average cell speed of differentiated HL-60 cells without coating (control), on 100 µg/ml bovine
fibronectin coating (bFN coating), and on heat-treated bovine fibronectin coating (HT bFN coating).
Heat treatment of the coating significantly reduced average cell speed. Error bars represent 95 % CIs.
F. Direction autocorrelation of differentiated HL-60 cells on control, bFN and HT bFN coatings at
37 ◦C. Heat treatment of bovine fibronectin did not influence cell persistence. Error bars are S.E.M.
For all: N = 2 independent experiments were performed. ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001.
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6.5 Thermotaxis in differentiated HL-60 cells on 2D sur-
faces
The ability of the neutrophil-differentiated HL-60 cells to sense temperature gradients and
thermotax in response was investigated on 2D glass surface using a microfluidic temperature
gradient system (see Materials and methods, Fig. 5.1A). Computations performed using
COMSOL Multiphysics showed the temperature gradient along the whole microchamber was
uniform with a range from 27 ◦C to 43 ◦C (see Materials and Methods, Fig. 5.2). For 2D
studies, differentiated HL-60 cells were injected into the microchamber at a concentration of
150 cells/mm2. The temperature gradient in the 2D microchamber resulted in heat transfer
by convection, which caused media flow from the heat sink to the heat source above the
glass surface. Up to 60 % of cells detached in the microchamber, possibly due to elevated
temperatures in regions of the chamber (Fig. 6.6A). Of the cells that remained adherent,
the majority (∼ 70 %) either remained in place or migrated very little from their position.
These cells were considered to be non-mobile cells (Fig. 6.6A). The remaining mobile cells
were classified into three subpopulations based on their final positions within equally-sized
120◦ polar divisions: cells migrating toward the heat source (positive thermotaxis), cells
migrating toward the heat sink (negative thermotaxis), and cells moving perpendicular to the
temperature gradient (Fig. 6.6A and C). Based on these divisions, 40 % of cells were found
to exhibit positive thermotaxis and 50 % of cells negative thermotaxis. Interestingly, only
approximately 10 % of motile cells finished in the perpendicular subpopulation, compared
to an expected value of 33 % for unbiased migration (Fig. 6.6A). To quantify this tendency,
the relative angles θ between each cell step greater than 2 µm were calculated and plotted
as a polar histogram, revealing significant migrational bias along the temperature gradient
(Fig. 6.6D). The migration speed of motile differentiated HL-60 cells was also evaluated.
Independent of migration direction, the average cell speed in the presence of the temperature
gradient was approximately half the average speed of cells in a constant 37 ◦C environment.
No significant difference was found between the average speed of positively or negatively
thermotaxing cells (Fig. 6.6B).
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Figure 6.6: Differentiated HL-60 cell thermotaxis in response to temperature gradients in 2D
microchambers. A. Temperature gradient effects on cell adhesion and migration in 2D. After
application of the gradient, ∼ 40 % of cells remained attached. 72 % of the attached cells were non-
mobile. Of the mobile cells, approximately 50 % migrated towards the heat sink (negative thermotaxis)
and 40 % migrated towards the heat source (positive thermotaxis). B. Differentiated HL-60 cell
speed in 2D in the presence of the temperature gradient. 25 cells in each direction were tracked. No
significant differences in cell speed were found between those moving towards the heat source and
those toward the heat sink, but both were approximately 50 % slower than those in a constant 37 ◦C
environment. C. Migration tracks of 50 cells migrating both towards and away from the heat source.
Cells that migrated at an angle of 60◦ or less with respect to temperature gradient direction (in this case
the Y axis) were considered to have directed migration towards either the heat source or sink (red and
blue triangles). 10 % of cells showed non-directed migration. D. Polar histogram of the relative angles
from cell step to cell step calculated for 50 cells tracked under temperature gradient in 2D. Small steps
less than 2 µm were disregarded. For all: N = 2 independent experiments were performed. Error bars
represent 95 % CIs of the data. ∗∗∗∗P < 0.0001, N.S. not significant. Significance was evaluated by
ordinary one-way ANOVA.
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6.6 Differentiated HL-60 cell migration under shear flow
To determine whether directed migration towards the heat source was affected by the gradient-
generated fluid shear stress, additional migration studies of differentiated HL-60 cells under
laminar flow were performed. To approximate the flow rate created in the 2D temperature
gradient chamber, the average floating speed of 60 detached cells at different positions was
calculated (35.5 µm/min). Using a commercial microchamber flow cell with the same height
as the temperature gradient microchannel and a syringe pump, it was established that flow
rates of 30 µl/hour resulted in an average detached cell floating speed of 37 µm/min, i.e.
similar to that observed in the 2D temperature gradient chamber. A higher 40 µL/hour flow
rate was also applied, resulting in a higher shear flow rate that doubled the floating speed of
detached cells (80.5 µm/min).
The speed with which the differentiated cells migrated under the applied flow conditions
was significantly lower than the speed of the control cells at 37 ◦C without any external
stimuli (Fig. 6.7A). Although 40 µL/hour flow resulted in slower cell migration than 30
µL/hour flow, neither flow rate was sufficient to induce directional bias (Fig. 6.7B). This
suggested that cells in the 2D temperature gradient microchannel were unlikely to be affected
by the gradient-induced convective flow, and thus, their directional bias was a result of the
temperature gradient.
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Figure 6.7: Fluid shear flow of a similar magnitude to that produced by temperature gradients
does not induce directed migration. A. Cell speed of differentiated HL-60 cells in 2D in the
presence of a temperature gradient and under laminar flow of 30 and 40 µL/hour. The average speed of
50 cells in total was evaluated for each condition. In the 2D temperature gradient chamber, 25 cells in
each direction were tracked at a sampling interval of 15 seconds. No significant difference between
migration speed of cells moving towards either heat source or sink was found by Welch’s t-test. When
compared with cell speed in a constant 37 ◦C environment (sampling interval 10 seconds), cell speed
was reduced by approximately 50 %. Application of shear flow also resulted in significant cell speed
reduction. Lower cell velocities could partially be an artifact of the lower cell tracking rate of 60
seconds, but the significant differences in cell speed under lower and higher flow rates indicate that
cell migration speed has an inverse relationship to flow rate. B. Migration tracks and polar histograms
of θ for 50 cells migrating under laminar flow conditions. Application of 30 and 40 µL/hour flow rates
did not result in directional cell migration.
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6.7 Thermotaxis in differentiated HL-60 cells in 3D colla-
gen gels
Cell migration on 2D surfaces differs considerably from migration in the 3D microenvironment
in vivo. To better mimic in vivo confinement, a new 3D temperature gradient chip was
produced featuring a 3D cell reservoir (see Materials and Methods, Fig. 5.1B). 20 cells were
tracked at both a constant 37 ◦C and under temperature gradient conditions equal to those
produced in the 2D microchannel (8.0 ◦C/mm). In the absence of the gradient, cells exhibited
migration without directional bias (Fig. 6.8A). When the temperature gradient was applied,
65 % of the tracked cells migrated towards the heat source. Cells in the 3D microchamber
migrated much slower than cells on 2D surfaces, in agreement with the literature [28], with
no significant difference found between cells at a constant temperature and those in the
temperature gradient (Fig. 6.8B).
Figure 6.8: Differentiated HL-60 cell thermotaxis in response to temperature gradients in 3D
microchambers. A. Migration tracks and polar histograms of θ for 20 cells each, migrating in 3D
collagen matrix with and without temperature gradients. Application of the temperature gradients
in 3D revealed a higher percentage of cells migrating towards the heat source. B. Cell speed of
differentiated HL-60 cells in a 3D collagen matrix at a control temperature of 37 ◦C and in the presence
of the temperature gradient. The average speed of 20 cells in each condition was evaluated. For all:
Error bars represent 95 % CIs of the data. N = 2 independent experiments were performed. N.S. not
significant.
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Chapter 7
Discussions
Many external factors affect cell behavior. Despite 37 ◦C being the average core temperature
of the human body, thermal variations still occur both on macro (tissue) and micro (cell)
scales. As an example, inflammation is accompanied by increased heat due to the augmented
blood flow in the injured or infected tissue. It is reasonable to assume that these extracellular
changes in temperature can have an influence on the cells, in particular the immune cells
recruited to the inflammation sites. However, very little studies have been done to understand
temperature effects on cell behavior in general and cell migration in particular.
One of the most notable studies of temperature effects on immune cells, done by Malawista
et al., showed an interesting ability of neutrophils to form autonomous motile fragments
(CKPs) through detachment of cell protopods from the cell body under short-termed heat
treatment of approximately 45 ◦C [20, 21, 67, 68]. In another study, Díaz et al. [182] showed
that fever-range hyperthermia combined with low pH in the environment, which is often
present in inflamed and cancerous tissues, significantly increased neutrophil survival. In the
present study, the role of physiologically relevant temperatures (30-42 ◦C) on immune cell
adhesion, migration speed, and directionality was systematically analyzed using neutrophil
differentiated HL-60 cells as a model cell line.
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7.1 CKP formation was not possible in neutrophil differen-
tiated HL-60 cells due to the reduced cell adherence at
elevated temperatures
Results presented in Section 6.2 showed that human neutrophils isolated form venous blood
formed autonomous motile cytokineplats when heated to approximately 47 ◦C (Fig. 6.2A).
In contrast, CKP formation was not observed with neutrophil differentiated HL-60 cells.
According to Malawista et al., neutrophil attachment and motility play a key role in fragment
formation. Their experiments with non-adherent blood neutrophils and less motile leukocyte
cells, such as monocytes, did not lead to motile fragment production [21]. As average cell
velocities of differentiated HL-60 cells are comparable to that of blood neutrophils (see
Appendix, Fig. A.1), the inability of these cells to form CKPs at elevated temperatures is
likely due to the cell detachment observed already at 40 ◦C (see Results Chapter 6, Figs. 6.3B
and 6.4A).
Two different seeding conditions were used to improve cell adherence: bovine fibronectin
coating (bFN) and media containing elevated serum concentration (5X FBS). To recapitulate,
fibronectin coating did not improve cell adherence, whereas increased levels of FBS led to
significantly higher numbers of adhering cells at all the applied temperatures (see Results
Chapter 6, Fig. 6.4A). This could be due to high levels of surface-adsorbable ECM proteins
commonly found in serum [183], which provide an increased number of binding ligands at
the cell-surface interface. As the elevated levels of serum were maintained throughout the
experiment, it is also possible that the resulting increase in soluble protein concentration in the
media also encouraged attachment and cell migration. Regardless of the seeding condition,
the highest temperature at which any adherent and migrating cells were observed was 44 ◦C, a
temperature, which was insufficient to produce autonomous motile fragments in differentiated
HL-60 cells.
7.2 Temperature-dependent increase in cell speed and re-
duction in cell persistence time lead to equal persistence
length in migrating neutrophil-differentiated HL-60 cells
Temperature-dependent differentiated HL-60 cell motility was studied by stepwise increasing
the temperatures from 30 to 42 ◦C (see Materials and Methods, Section 5.2.3.1). In the Results
Chapter 6 (Section 6.4) it was shown that with increasing temperature cell average velocity
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rose nearly linearly independently of seeding conditions. The results may be explained by
acceleration of actin polymerization corresponding to increases in temperature, as described by
Rosin et al. [47]. Additionally, it has been shown that overall F-actin concentration in PMNs
increases in response to external signals. Howard et al. [47] showed that both chemoattractant
signaling and the application of elevated temperature are sufficient to cause an increase in
F-actin concentration in human blood neutrophils. They showed that between temperatures
of 30 ◦C and 40 ◦C, F-actin concentration increases linearly, resulting in doubling by 40 ◦C.
Assuming that these temperature-driven changes in actin occur similarly in HL-60 cells, these
previous findings support the above-mentioned hypothesis that linear increases in the average
speed of the neutrophil-like cells could be a result of higher F-actin polymerization rates and
subsequent increases in absolute F-actin levels as a result of increasing temperature.
Independent of the temperatures applied, fibronectin coating significantly reduced cell speed
compared to cells migrating under control and 5X FBS conditions. This decrease might be
due to the stronger adhesion promoted by fibronectin, resulting in an altered cell migration
speed, as observed by other studies [34, 184]. As fibronectin is known to unfold and expose
additional binding ligands [185], it is possible that the heat treatment encourages irreversible
unfolding or altered refolding. Such changes may lead to the significant reduction of cell
speed on heat-treated fibronectin coatings (see Results Chapter 6, Fig. 6.5E).
As part of the motility studies, temperature dependent cell persistence was also evaluated
using direction autocorrelation analysis (see Results Chapter 6, Fig. 6.5). To obtain the
average persistence time, autocorrelation curves were fitted with a one phase exponential
decay model c+ ae−t/τ , where τ is the persistence time. Using non-zero values for constant
term “c” significantly improved the quality of the fit. The nonzero value of the constant could
imply a correlation between cell directionalities at large time offsets. As these experiments
were performed by homogeneously increasing the temperatures throughout the samples, i.e.
in absence of external directional signal, the non-zero values could imply an inherent cell
directionality at migration on large time scales. There are several examples of cells exhibiting
correlated migration even in the absence of external directional signals. Li et al. [28] showed
that Dictyostelium discoideum, an amoeba exhibiting fast motility and chemotactic behavior
similar to neutrophils, are capable of directed motion by “remembering” their last turn, even
in the absence of an external signal. This improves their search efficiency relative to random
walk and allows them to search more territory. Of course, the autocorrelation data could
have been fitted well by a double exponential model, meaning that the autocorrelation curves
reflect at least two processes. However, it would be difficult to elucidate what these processes
represent during cell migration and give the appropriate weight to each of them.
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As described in the Results Section 6.4, the estimated persistence time for all conditions
showed a decrease with increasing temperature. This decrease meant that at higher tempera-
tures, despite higher migration velocities, the cells made more frequent turns. The relationship
between cell persistence time and cell speed has been examined in a number of cell models
[186, 187]. In general, as cell speed increases, cell persistence increases concomitantly,
up to a plateau value [186]. Here, when increases in speed are a function of increases in
temperature, the opposite effect was observed, as persistence time decreased with increasing
temperature (see Appendix, Fig. A.2).
The drop in the persistence time could be due to the temperature-dependent changes in
membrane fluidity. Houk et al. have shown that membrane tension plays a pivotal role during
directed neutrophil migration by restricting the signaling molecules to the leading edge of the
cells [64]. Accordingly, decreases in membrane tension cause a loss of polarity. An increase in
temperature results in higher membrane fluidity, which in turn reduces membrane tension and
can cause cells to stop and turn more frequently, resulting in a decrease in cell persistence time.
In contrast, as previously mentioned, increases in temperature also increase the rate of F-actin
polymerization and the total amount of F-actin in the cell, which leads in higher cell migration
velocities. Based on the results presented in Figure 6.5D (see Results Chapter 6), it can be
speculated that these two factors combine to balance each other out, causing cells to have an
approximately constant persistence length at temperatures higher than 33 ◦C. Furthermore,
even in conditions that cause a significant reduction in cell speed, like fibronectin coating
(see Results Chapter 6, Figs. 6.4B and 6.5F), persistence length remains constant. These
results could indicate, that adherent immune cells have an innate persistence, unaffected by
ECM composition or temperature, allowing them to navigate microenvironments with diverse
protein compositions and thermal conditions. It can be theorized that the preservation of
persistence length confers an advantage to immune cells migrating at higher temperatures,
as they are able to cover more ground in search of their target independent of extracellular
matrix composition. The effect of elevated temperatures on membrane fluidity may also be
favorable to immune cells, as it allows for faster adaptation of migration direction in response
to obstacles.
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7.3 Differentiated HL-60 cells exhibited “positive” and “neg-
ative” thermotaxis in 2D
The ability of HL-60 neutrophils to sense and react to temperature gradients was examined
both on 2D glass surfaces and in 3D collagen gels. Despite the high number of detaching
cells in 2D, the remaining motile cells could be divided into two subpopulations exhibiting
“positive” (migration towards heat source) and “negative” thermotaxis (migration towards
heat sink) (see Results Chapter 6, Fig. 6.6). While primary neutrophils have been shown
to exhibit positive thermotaxis [188], negative thermotaxis has not been observed. Based
on the previous observations, a significant number of the differentiated HL-60 cells detach
in response to increasing temperatures (Results Chapter 6, Fig. 6.3 and 6.4A). Hence, the
“negative” thermotaxis of the second cell population could be attributed to cell migration
from a weakly adherent surface to strongly adherent surface in a manner similar to haptotaxis.
The cells embedded in 3D collagen also showed a small, but not significant, tendency of
differentiated HL-60 cells to migrate along the temperature gradient as 65 % of the tracked
cells migrated in the direction of heat source. These findings, especially on 2D surfaces, show
that neutrophil differentiated HL-60 cells can be a valuable tool for investigating immune cell
thermotaxis, a complex process that is not yet well understood.
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Chapter 8
Results
In the study described in this chapter, Crispr/Cas9 PKD1, PKD2, PKD3 Panc1 and control
Panc1 cell lines were used to investigate PKD isoform-mediated pancreatic cancer cell
migration and invasion.
8.1 PKD-isoform dependent Panc1 cell attachment, prolif-
eration and morphology
PKD isoforms have been reported to modulate cancer cell proliferation and morphology
[170], [161]. To assess cell attachment efficiency and proliferation rate of CRISPR/Cas9
PKD1, PKD2 and PKD3 Panc1 knockout cells, the cells were seeded into petri dishes and
the cell number was then monitored over 72 hours (Fig. 8.1). The data suggests that PKD1
KO cells had significantly lower attachment efficiency (see Materials and Methods, Equation
5.2) compared to the wild type, the PKD2 KO and PKD3 KO cell lines. The proliferation
rate, estimated as the change in cell number over 48 hours (see Materials and Methods,
Equation 5.3), was also reduced, although not significantly. On the contrary, PKD2 KO cells
exhibited significantly better attachment efficiency and proliferation rates approximately 1.8
times higher than the control cells. No changes in attachment and proliferation were observed
for PKD3 isoform knockout in comparison with the control.
PKD isoform dependent changes in cell morphology were observed as well (Fig. 8.2). Quali-
tatively, based on their shape, the cells could be classified into 3 categories: epithelial-like,
mesenchymal-like and mixed (Fig. 8.2A). Maupin et al. described similar cell classification
for different pancreatic cancer cell lines [171]. Based on this division, Panc1 wild type and
PKD3 KO cells were in the mixed category, as both epithelial (rounded cells with cell-cell con-
tacts) and mesenchymal (elongated cells with little cell adhesions) phenotypes were present.
CHAPTER 8. RESULTS 68
Figure 8.1: Attachment efficiency (A) and cell proliferation (B) over 48 hours of PKD1 KO,
PKD2 KO, and PKD3 KO cells. Loss of PKD1 isoform led to significantly lower attachment
efficiency as well as reduced proliferation rates of the Panc1 cells. On the contrary PKD2 knockout cells
exhibited increase in cell propagation. No changes in either cell attachment efficiency (Equation 5.2)
or cell proliferation (Equation 5.3) were observed for PKD3 KO cells. For all: Error bars represent
95 % Confidence Interval. N = 3 independent experiments; ∗∗∗P < 0.001,∗∗∗∗P < 0.0001, N.S. not
significant. Significance was evaluated by ordinary one-way ANOVA.
PKD1 KO exhibited clear mesenchymal-like spindle-shaped morphology. Concurring with
this observation, quantitative analysis of cell morphologies also showed significant increase in
PKD1 KO cell aspect ratio (Fig. 8.2C). Interestingly, PKD2 KO cells exhibited the opposite
behavior and would grow in clusters creating epithelial-like sheets (Fig. 8.2A). Knockout of
either isoform did not influence cell area (Fig. 8.2B).
E-cadherin, a crucial transmembrane glycoprotein involved in cell-cell adhesions, is one of
the main epithelial cell markers. Indeed, during epithelial-to-mesenchymal transition (EMT)
many cells exhibit E-cadherin downregulation. Panc1 cancer cell line has been shown to have
low E-cadherin expression [171]. E-cadherin re-expression and/or upregulation has been also
linked to the reverse process of mesenchymal-to-epithelial transition (MET) [189], [190].
Immunofluorescent staining of this glycoprotein in the Panc1 control, PKD1 KO and PKD3
KO cells showed only E-cadherin cytoplasmic localization (Fig. 8.3). PKD2 KO cells
exhibited distinct patterns of membranous E-cadherin expression at the intercellular borders.
This indicates that the PKD2 isoform is a positive regulator of EMT transition in Panc1 cells
and loss of it drives the reverse change from mesenchymal to epithelial phenotype.
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Figure 8.2: PKD enzymes regulate cell morphology in an isoform specific way. A. Representative
phase contrast images of Panc1 control, PKD1 KO, PKD2 KO and PKD3 KO cells in 2D culture. Based
on morphological presentation the cells were divided into 3 categories: mesenchymal (PKD1 KO cells),
epithelial (PKD2 KO cells) and mixed (Panc1 control and PKD3 KO cells). PKD1 knockout cells
exhibited defined spindle-like morphology, whereas in absence of PKD2 the cells grew in epithelial
like clusters. Scale bars: 200 µm. B. Cell area was evaluated after 24 hour cell culture on glass slides
as described in Materials and Methods (Section 5.2.5.1). The cell area was not influenced in absence
of either isoform (N = 2). C. Significant increase (∗∗∗P < 0.001) in PKD1 KO aspect ratio further
proved PKD isoform involvement in cell morphology regulation. For all: Error bars represent 95 %
Confidence Interval. N = 2 independent experiments; N∗ = 30 total cells analyzed; significance was
evaluated by ordinary one-way ANOVA.
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Figure 8.3: Representative immunofluorescent confocal images of E-cadherin (green) and nuclei
(blue) in fixed Panc1 cells with PKD1, PKD2 and PKD3 knockouts. Brightness and contrast of
the images were adjusted for each cell line. Strong membranous E-cadherin expression could be
observed at the intercellular borders in PKD2 knockout cells further attesting to the adaptation of the
epithelial phenotype. Panc1 control, PKD1 and PKD3 knockout cells exhibited primarily cytoplasmic
E-cadherin expression indicative of mesenchymal phenotype. For all: Scale bars: 20 µm
8.2 PKD isoform dependent cell motility in 2D
A major factor defining the highly malignant and invasive cancer cell lines is the enhanced
motility they exhibit both in vitro and in vivo. In order to assess changes in cell migration
speed and persistence with regards to the absence of one of the PKD isoforms in 2D, the cells
were seeded on glass-bottomed petri dishes. After overnight incubation at 37 ◦C, the cells
were imaged at a 10–minute interval for 24 hours. The cells were then tracked manually and
the average cell velocity was calculated (Fig. 8.4). The cell average speed of the Panc1 cells
did not change in response to PKD1 knockout (Fig. 8.4A).
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Figure 8.4: 2D Panc1 cell migration speed is dependent on the presence of PKD2 and 3 isoforms.
A. Average cell velocity was evaluated by tracking the cells over a 24-hour period. PKD1 knockout in
Panc1 cells did not affect the average cell velocity. In contrast, deletion of PKD2 and PKD3 isoforms
significantly (∗∗∗P < 0.001,∗∗∗∗P < 0.0001) reduced cell speed. B. Representative tracks of migrating
Panc1 control and PKD1, PKD2 and PKD3 knockout cells. PKD2 KO and PKD KO cells retained their
rounded shape and would migrate only small distances from their original tracking position. C. Rose
plots of cell migration tracks. Although PKD1 KO did not affect cell speed, Panc1 cell persistence
improved with the knockout of that isoform. For all: Error bars represent 95 % Confidence Interval.
N = 3 independent experiments; N∗ = 45−55 total cells analyzed; significance was evaluated using
ordinary one-way ANOVA.
In contrast, absence of PKD2 and PKD3 significantly hindered Panc1 cell migration. In both
cell lines the average speed drastically slowed down (approximately 1.5 - 2-fold decrease)
and the cells, retaining their rounded shape, would migrate only small distances from the
original position of tracking (Fig. 8.4B). Very small number of single cells exhibited migratory
behavior in the PKD2 KO cell line. As described in the previous chapter, these cells would
proliferate and grow in epithelial-like sheets, preferring collective migration at high cell
densities. An important parameter describing cell motility is the persistence. As described
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in the Introduction (Section 1.2), cells have innate persistence regardless of extracellular
signaling.
From the rose plots of cell tracks (Fig. 8.4C), it is clearly visible that, despite no significant
changes in cell average velocity, PKD1 KO cells could cover larger area, which is a sign of
higher persistence in these cells. To quantify this observation, mean square displacement
(MSD) analysis was performed on the cell tracks (see Materials and Methods, Section 5.2.5.1).
Figure 8.5: Mean square displacement (MSD) analysis of cell migration dynamics in 2D re-
vealed strong PKD isoform dependence of the cell persistency. A. Double logarithmic plot of the
average MSD of cell trajectories over a 4-hour migration period fitted with persistent randpm walk
(PRW) model (black line). Average persistence time (Pt) of PKD1 KO cells, acquired from PRW fit,
was 4 times higher than of control Panc1 cells. The higher persistence resulted in increased MSD
values over extended time periods. PKD2 knockout cells had an approximately 2-fold increase in
Pt, but due to the reduced cell speed, they exhibited lower MSD values. PKD3 KO cells were the
least persistent Pt approximately 2 times lower than the control cells). Error bars represent S.E.M. B.
Log-log MSD slopes showing time-dependent changes in cell persistency. Knockout of both PKD1
and PKD2 isoforms resulted in extended transition periods from semi-persistent (β(t) ∼ 1.5) to random
migration modes (β(t) ∼ 1.0). For all: N = 3 independent experiments; N∗ = 45−55 total cells
analyzed.
Figure 8.5A depicts double logarithmic plot of the average MSD of the cells over a 4-hour
observation period. To obtain the persistence time, the average time period during which
cells migrate in a correlated fashion, MSD curves were fitted with a persistent random walk
(PRW) model (see Materials and Methods, Equation 5.4). PKD1 KO cells showed 4-fold
increase in average persistence time (16.53 ± 0.75 min) compared to the control cells (4.41 ±
0.48 min), confirming the previous observation that absence of PRKD1 gene (the gene that
produces the PKD1 enzyme), leads to more directed migration of pancreatic cancer cells
and overall to a bigger area explored. Interestingly, knockout of the PRKD2 gene also led to
higher persistence time (9.06 ± 0.76 min). Nevertheless, due to reduced cell speed, the overall
MSD of PKD2 KO was lower than that of the Panc1 cells (Fig. 8.5A). In contrast, PKD3 KO
73 CHAPTER 8. RESULTS
cells exhibited 2-fold drop of persistence time. The latter, combined with low cell speed, lead
to the least lowest MSD values.
Mean square displacement has a time interval dependence that follows a power law MSD ∝ tβ ,
with 0 < β< 2. The linear dependence is associated with Brownian motion, i.e. random
migration. Deviation from the linear behavior denotes subdiffusive, constraint (0 ≤ β≤ 1) or
superdiffusive (1 ≤ β≤ 2) migration modes. In the absence of an extracellular guiding signal,
cells migrate in a correlated manner in shorter time intervals and at longer observation periods
they loose the persistency (β ∼ 1). To illustrate time dependent changes in the directional
persistence, the logarithmic derivative of MSD (β(t)) (see Materials and Methods, Equation
5.5) was plotted as a function of time interval (Fig. 8.5B). As it can be seen, PKD1 KO
and PKD2 KO cells had longer transition periods from semi-persistent (β(t) ∼ 1.5) to fully
random (β(t) ∼ 1.0) migration mode. PKD3 KO cells exhibited only random motion with β(t)
fluctuating around 1.0.
8.3 Changes in F-actin arrangement and focal adhesion mor-
phology in response to PKD isoform specific protein
deletion in Panc1 cell line
Taking into consideration the dependence of cell morphology and motility on cytoskeletal
organization, filamentous actin (F-actin) and the focal adhesion (FA) protein Vinculin were
immunofluorescently stained to reveal any possible changes in response to PKD isoform dele-
tion. Figure 8.6 contains representative confocal images of F-actin (red) and Vinculin (green).
In Panc1 control cells, F-actin stress fiber bundles were disorderly arranged throughout the
cell body, with elongated focal adhesions anchoring the cells to the substrate. FAs could
be observed both in the cell interior and its periphery. PKD1 KO cells had similar F-actin
organization, but FAs were smaller and formed primarily at the cell periphery. PKD2 KO cells
exhibited drastic changes both in F-actin and FA organization and localization. Actin bundles
were absent in the cell center but formed very organized stress fibers at the cell periphery,
with very large focal adhesions present at the cell membrane protrusions. The distinct features
of PKD3 KO cell cytoskeleton were mesh like F-actin organization with little to no stress
fibers, and small, rounded FAs dispersed throughout the cell body.
CHAPTER 8. RESULTS 74
Figure 8.6: Representative immunofluorescent images of F-actin (red) and Vinculin (green) in
fixed Panc1 cells with PKD1, PKD2 and PKD3 knockouts. The images were taken with a confocal
microscope; the brightness and contrast of the images were adjusted for each cell line. Changes in
F-actin organization and focal adhesion size and distribution were observed in all three knockout cells.
PKD1 knockout led to no FA formation in the cell exterior and smaller focal adhesion areas at cell
periphery. PKD2 knockout cells had no F-actin fibers in cell interior, but exhibited high density and
highly oriented F-actin stress fibers, as well as very large focal adhesions at the cell periphery. PKD3
knockout cells had mesh-like F-actin organization with little to none stress fibers and formation of
small, rounded FAs throughout the cell body. For all: Scale bars: 20 µm.
8.4 PKD-isoform dependent Panc1 cell contact guidance
on microgrooved substrates
One phenomenon observed in invasive cancer types in vivo is the high cross-linking of
tumor-surrounding extracellular matrix with increased directional orientation of ECM fibrils.
The changes in ECM alignment create topographical signaling cues for directed cancer cell
invasion into the stroma. In vitro studies of cell contact guidance, which is the ability of the
cells to orient towards geometrical patterns and migrate along them in a directed manner, were
carried out using micro- and nano- structured surfaces developed previously in our group [36].
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Cells were seeded on fibronectin functionalized PDMS substrates with defined 200 and 350
nm deep, 2 and 10 µm wide grooves. After overnight incubation, the cells were imaged for 20
hours using phase contrast microscopy. Cell morphology, orientation and motility were then
evaluated as described in Materials and Methods (Section 5.2.5.2).
All cell lines exhibited some degree of contact guidance, but the most significant changes
were observed in PKD1 knockout cells (Fig. 8.7). When looking at cell morphology, these
cells exhibited extreme cell body elongation, which was quantified as a change in cell aspect
ratio (Fig. 8.7B). Both on 200 and 350 nm deep grooves, PKD1 KO cells had approximately
1.5- to 2-fold increase in the average aspect ratio compared to the same cell line on a flat
PDMS surface. Correlated with cell elongation, cell-spreading area was also affected and was
significantly reduced on these substrates. The biggest changes were observed on 2 µm wide
grooves. On average, Panc1 control cells exhibited higher AR values – yet only on the 350
nm deep and 2 µm wide grooved structures, which is the geometry that provides the strongest
guiding cues. PKD2 and PKD3 knockout cells seeded on the structured substrates did not
exhibit any morphological changes.
Cell alignment along the grooves was estimated using the apolar orientation parameter S (see
Materials and Methods, Equation 5.7). S is a dimensionless parameter, with −1 < S < 1. The
closer S is to 1, the better the cell is aligned along the grooves, whereas S = 0 and S = -1 are
random and perpendicular alignments respectively. As it can be seen from Figure 8.8, S was
highly dependent on structural characteristics of the substrates, as well as on the absence of
specific PKD-isoforms. All the cell lines exhibited some degree of alignment (S > 0), but the
architecture of the substrates had the most prominent effect on PKD1 KO cells. The general
tendency for all the cells was that the finer the spacing and the deeper the grooves were the
more prominent the cell contact guidance was. Regardless of groove dimensions PKD1 KO
cells had the highest Order Parameter values compared with the rest of the cells. On 2 µm
wide grooves SPKD KO reached the significantly high values of 0.8 (D: 200 nm) and 0.93
(D: 350 nm). Despite the fact that no changes in cell morphology were induced by structured
surfaces, PKD2 and PKD3 knockout cells exhibited higher groove-sensitive cell alignment
compared to the control Panc1 cells. Already on 200 nm deep and 2 µm wide grooves, these
cells exhibited an improved contact guidance with order parameter values twice as high as the
ones measured for the control cells. Panc1 wild type cell orientation was affected only on the
more structurally defined surfaces (D: 350 nm, W: 2 µm).
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Figure 8.7: Only PKD1 knockout had effect on Panc1 cell morphology plated on microgrooved
substrates. A. Panel of representative phase contrast images of Panc1 control, PKD1 KO, PKD2 KO
and PKD3 KO cells on 350 nm deep and 2 µm PDMS substrates with wide grooves. Noticeably PKD1
KO cells exhibited extreme cell body elongation. Scale bars: 50 µm. B and C. Cell area and aspect
ratio (AR) ratio were significantly affected in PKD1 KO cells independent of groove dimensions. The
extreme cell body elongation along the grooves led to cell area reduction. Microgrooved surfaces did
not induce any morphological changes in the control, PKD2 KO and PKD3 KO cells. For all: Error
bars represent 95 % Confidence Interval. N = 2 independent experiments; N∗ = 30−50 total cells
analyzed; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001, N.S. not significant. Significance
was evaluated by ordinary two-way ANOVA.
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Figure 8.8: PKD isoform-specific knockouts in Panc1 cells induce enhanced cell align-
ment on structured substrates. Orientation Parameter S, which ranges between
−1(perpendicular)< 0(random)< 1(parallel), was used to quantify cell alignment as a function
of groove depth and width. All the cells plated on microgrooved PDMS substrates exhibited some
degree of alignment along the structures. All three isoform specific knockouts led to higher Orien-
tation Parameter values regardless of microgroove dimensions with the strongest alignment shown
by PKD1 KO cells. The absence of PKD1 led to almost perfect cell ordering on the grooves with
2 µm spacing (SPKD1 KO200nm = 0.8 and SPKD1 KO350nm = 0.93). Higher groove depth (350 nm) and
lower groove width (2 µm) architecture provided the strongest cues for all the cell lines. For all: Error
bars represent 95 % Confidence Interval. N = 2 independent experiments; N∗ = 30−50 total cells
analyzed. ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001, N.S. not significant. Significance was evaluated
by ordinary two-way ANOVA.
Cell contact guidance leads not only to cell alignment along the grooves but also in directed
movement along them. Migration displacement angles with respect to the groove direction
were plotted to reveal the degree of directional bias created by the surface architecture
(Fig. 8.9). The Rose plots show strong migration persistence in the x-direction parallel to the
grooves for all the cell lines, although PKD2 KO and PKD3 KO cells exhibited the lowest
persistency especially on wider 10 µm grooves. Panc1 control and PKD1 KO cells had a very
similar angle distribution profile. Independent of the cell line, the biggest bias was induced by
the narrow (2 µm) and deep (350 nm) grooves.
Due to the directional bias presented by the surface architecture, cell speed was also affected.
The average cell velocity as a function of groove dimension and isoform knockdown is shown
in Figure 8.10. As expected all the cell lines had significantly elevated mean cell velocities
on the grooved PDMS surfaces. The changes in cell velocity followed the same trend as
described above. On average, PKD1 KO cells had the higher cell speed on the 200 nm
deep grooves.
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Figure 8.9: Rose plots of cell displacement angles. The angles were calculated from cell migration
vectors with respect to the groove direction (here x-axis). Steps smaller than 3 µm were disregarded.
Tall and narrow grooves were the most effective in biasing cell migration in all the cell lines. Loss of
PKD1 made the cells “sensitive” to the shallower structures (200 nm deep and 2 µm wide). 10 µm
wide grooves provided a strong signal for directed migration only combined with 350 nm depths.
Concurrent with the results on 2D glass surfaces (Section 8.2), PKD3 KO cells exhibited the lowest
persistency on all substrates except the deeper and narrower ones (D: 350 nm, W: 2 µm).
In contrast, on 350 nm deep structures, Panc1 control cells were faster, showing significant
differences on 2 µm wide grooves.
To summarize all the results described in this section, absence of PKD1 isoform in Panc1
cells resulted in significant morphological changes, such as extreme cell elongation along the
grooves. No morphological changes were observed for the rest of the cell lines plated on the
structured substrates. In contrast, cell alignment parallel to the grooves, average velocity and
migration persistence were affected to some degree in all the cell lines, with the strongest
effect observed for PKD1 KO cells. All the cells had higher contact guidance efficiency on
smaller groove spacing (2 µm combined with higher groove depth (350 nm).
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Figure 8.10: Cell average velocity as a function of groove dimensions and PKD isoform-specific
knockout. All the cell lines migrated faster on microstructures compared to the flat PDMS sur-
face. Concurrent with the directionality analysis, all cell lines were faster on the deeper and nar-
rower ones (D: 350 nm, W: 2 µm), with Panc1 control and PKD1 KO cells being significantly
faster than PKD2 and PKD3 KO cells. PKD1 KO cells were also significantly faster (∗P < 0.015)
than the control cells on 200 nm deep and 2 µm wide grooves. For all: Error bars represent
95 % Confidence Interval. N = 3 independent experiments; N∗ = 30−50 total cells analyzed.
∗P < 0.015, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001. Significance was evaluated by ordinary two-
way ANOVA.
8.5 PKD isoform-specific knockout Panc1 single cell inva-
sion studies
One of the goals of this work was to understand Protein Kinase D isoform-specific involvement
in pancreatic cancer cell invasive behavior. Among the key aspects of invasion is the ability
of cancer cells to deform their body in order to migrate through gaps of different sizes in the
highly cross-linked ECM network. To mimic this environment in well-controlled manner,
PDMS-based devices with micron scale channels were used, to investigate cell migration in
stiff confined environment. These microchips were previously developed in our group and are
a powerful tool for single cell in vitro invasion studies [175]. By using two different channel
dimensions of 3x11x150 µm3 and 10x11x150 µm3 (WxHxL) the degree of cell mechanical
deformability could be assessed as well. Considering that the diameter of pancreatic cancer
cells in suspension is approximately 20-25 µm, migration through 3 µm channel would require
dramatic deformations of cell cytoskeleton and the nucleus. At the same time, migration
through 10 µm wide confinement would not necessitate such extreme morphological changes.
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The cell lines were seeded in the microchips, and after overnight incubation, the cells were
imaged for a 48-hour period using phase contrast microscopy (see Materials and Methods,
Section 5.2.5.3). Only single cell-channel interactions were then analyzed. The interactions
were divided into three categories: Penetration, invasion and permeation [175]. Cells that
partially extended into the channels (up to 50 % of the channel length), without fully entering
them, were classified as penetrating cells. Cells that completely entered or penetrated ≥ 50 %
without leaving the channels from the opposite side were counted as invasive cells. And lastly,
the cells that completely migrated through the channels were termed permeative cells (see
Materials and Methods, Fig. 5.5). Summary of the interaction categories with respect to cell
type and channel dimensions is presented in figure 8.11A and B. Permeating cell migration
velocity inside the channels was analyzed as well (Fig. 8.11C).
Each of the cell lines exhibited different behavior inside the microchannels. In 3 µm channels,
Panc1 control cells were more permeative than any of the PKD isoform knockout cells. Upon
contact with the channels 46 % of the control cells were able to fully permeate (Fig. 8.11A).
Moreover, only 18 % of the cells were invasive, meaning that once the cells squeezed and
entered the channels they would likely migrate all the way through. In the absence of
PKD1 or PKD2 isoforms the ratio of the cell-channel interactions changed and became
more uniform (approximately 33 % each permeation, invasion and penetration). From the
perspective of PKD1 knockout, this result was quite surprising, as their ability to elongate on
the microstructures would hint to them being more deformable and hence more permeative in
the narrow channels. In contrast, the deletion of PKD3 in the Panc1 cells reduced the number
of the fully permeating cells by 17 % percent. As mentioned before, 10 µm channels do not
pose a big challenge with respect to cell deformation. Hence the cells had higher percentage
of fully permeating cells: Panc1 cells 1.4- fold increase, PKD1 KO 2- fold increase, PKD3
KO 1.7- fold increase. PKD2 knockout cells were the only exception with approximately the
same ratio of penetration, invasion and permeation as in 3 µm channels. Figure 8.11B shows
the number of the cells that interacted per one channel in one-day period. Surprisingly, PKD1
KO cells were least likely to initiate contact and invade the 3 µm wide channels.
In the next step, the migration speed of the cells inside the channel was evaluated by tracking
the leading edge of the cells. As it can be seen from Figure 8.11C channel dimensions did
not affect migration speed of the Panc1 control, PKD2 KO and PKD3 KO cells. Surprisingly,
absence of PKD1 significantly reduced cell speed (approximately 2.5- fold drop) in 3 µm
wide channels both compared to the control cells and the PKD1 KO cells in the wider (10 µm)
channels. It is obvious, that the highly confined environment had a very strong effect on
PKD1 KO cell invasive behavior in vitro.
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Figure 8.11: Single cell-channel interactions and confined cell average migration speed of Panc1
control, PKD 1, PKD2 and PKD3 knockout cells. A. Cell-channel interactions were divided into 3
categories: Penetration, invasion and permeation. Panc1 control cells were more effective at permeation
in 3 µm channels than any of the knockout cells. Out of 237 cells evaluated 36 % were penetrative,
18 % were invasive and 46 % permeative. PKD1 and PKD3 knockout cells exhibited similar and
relatively equal ratio of interaction types. Deletion of PKD3 was more effective at reducing cell
permeation in the narrow channels (29 % out of 167 cells). Higher percentage of Panc1, PKD1 KO
and PKD3 KO cells permeated the 10 µm wide channels. PKD2 KO cell-channel interactions were
not affected by changes in channel dimensions. N = 3 independent experiments; N∗3µm = 237 Panc1,
143 PKD1, 194 PKD2, 167 PKD3 and N∗10µm = 337 Panc1, 190 PKD1, 200 PKD2, 200 PKD3 total
cells analyzed. B. Number of interacting cells in a 24-hour period normalized by the total number of
channels available. PKD1 isoform knockout led to reduced number of total number of interacting cells
and poor permeation in 3 µm channels. C. In the absence of PKD1 enzyme average permeating cell
velocity in 3 µm wide channels was significantly (∗∗∗∗P < 0.0001) reduced compared to the control
cells and the PKD1 KO cells in 10 µm channels. Significance was evaluated by ordinary two-way
ANOVA.
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To better understand these changes, the phase contrast time-lapse movies were investigated
in greater detail. Figure 8.12A presents the image series of each of the cell lines migrating
inside the channels. Three important observations could be made:
• Control cells had no difficulty in permeating the narrow channels. As soon as the cells
deformed enough to squeeze through, they migrated promptly and left the channels
from the opposite side. PKD3 knockout cells behaved similarly, although due to the
speed decrease in these cells, they required much longer times to fully permeate.
• PKD1 KO cells exhibited extreme shape deformation in the 3 µm wide channels. Their
cell body could elongate to span the whole length of the channel, i.e. 150 µm, yet
their nucleus had difficulty deforming and entering the confined space (Fig. 8.12A). To
illustrate this, cell nuclei of fixed PKD1 KO and control cells inside the microchannels
were immunofluorescently stained. As it can be seen from the representative images
in Figure 8.12C, in Panc1 control cells the nuclei deformed almost immediately upon
cell entrance into the channels. In contrast, the nuclear deformation of PKD1 KO
cells happened when the cell body would reach approximately 80 % the length of
the channel, hence playing a role of a “plug” hindering cell permeation. This led
to the significant decrease in cell speed in the used confinement (Fig. 8.11C). The
cell membrane ruptured sometimes under such strain, which led to channel blockages
(Fig. 8.12B). Additionally, the channels were occupied for longer time periods since
one PKD1 KO cell could spend up to thirty hours inside one. This two factors combined
explained the calculated low number of cell interactions with the channels.
• PKD2 KO cells also behaved quite differently in the system used. As it can be seen
from Figure 8.12A (10 µm channels) and concurrent with the previous observations
the cells preferred collective cell migration, so-called cell streaming throughout the
channels. At low concentrations, single cells were able to interact with the channels
and permeate them in the same fashion as Panc1 control cells (8.12 2 µm channels).
The single cell migration inside the channels was as slow as on 2D surfaces. However,
due to much higher proliferation rates of Panc1 cells in the absence of PKD2 enzyme,
the cells created connective cell layers on both sides of the channels already after a
24-hour period.
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Figure 8.12: Representative phase contrast cell and immunofluorescently labeled nucleus im-
ages inside 3x11x150 and 10x11x150 µm3 (WxHxL) wide channels. A. For each of the cell lines
different permeation behavior was observed (see Section 8.5 for explanation). Cells were manually
outlined to improve visibitlity. B. PKD1 KO cells would sometimes rupture inside the narrow channels,
due to extreme and prolonged deformation inside them. C. Immunofluorescent staining of cell nuclei
of Panc1 control and PKD1 KO cells inside 3 and 10 µm wide channels. Nuclear deformation in
PKD1 KO cells starts when cell body of PKD1 KO cells reached approximately 80 % the length of the
channels. Scale bars: 50 µm.
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8.6 PKD1 isoform knockout induces changes in pancreatic
cancer cell mechanical properties
The ability of PKD1 KO cells to drastically deform was an indicator of changes in cell
mechanical properties of the cell. 3D optical stretcher was used to quantify cell stiffness.
The results are presented in figure 8.13. Cell deformability of PKD3 KO cells could not
be quantified due to both cell shape irregularity in suspension and bleb formation during
stretching (see Materials and Methods, Section 5.3 and Fig. 8.13A). The other three cell lines
were stretched at 1W laser power for two seconds. Cell deformability was measured as a
relative change in cell ellipticity (see Materials and Methods, Equation 5.8) and is shown
in Figure 8.13B as a function of time. Absence of PKD1 had a significant effect on cell
viscoelasticity. At maximum stretch time (t = 3s), PKD1 KO cells had approximately 1.6 %
and 2.6 % more change in cell ellipticity than the control and PKD2 KO cells respectively.
This confirmed the previous observations that these cells were much softer.
Figure 8.13: PKD1 KO cells are significantly more deformable. A. (i) Typical Panc1 cell in
suspension. The illuminated ring at the cell boundaries allows for automatic edge detection necessary
for deformation measurements. (ii-iv) Many of PKD3 KO cells had very irregular non-spherical
shapes in suspension (ii and iii), which rendered it difficult for the software to detect cell boundaries.
Additionally the cells with circular shapes would often form blebs upon stretching, possibly due to
actin cortex rupture (iv). Combined, these factors made it impossible to accurately measure PKD3 KO
cell deformation with the used assay. Scale bars: 10 µm. B. Average deformability curves of Panc1
control, PKD1 KO and PKD2 KO cells shown as relative change of cell ellipticity. The cells were
trapped at low laser power (100 mW) for 1 second, followed by 2 seconds stretching at 1 W laser power
(λ = 1064nm). PKD1 KO cells, which were previously identified as more invasive, are significantly
softer. C. At stretch end (t = 3 s), PKD1 KO cells had relative change of ellipticity of approximately
6.8 % and 1.6 % more than the control Panc1 cells (5.2 %). PKD2 KO cells were the least deformable
(4.2 %). For all: Error bars represent 95 % CI. N = 4 independent experiments; N∗ = 270 Panc1, 310
PKD1 KO, 320 PKD2 KO cells analyzed. ∗∗P < 0.01, ∗∗∗∗P < 0.0001. Significance was evaluated by
ordinary one-way ANOVA.
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Chapter 9
Discussions
Currently the 5-year survival rate for patients with pancreatic cancer is only 7-9 % [77].
Although it has slightly improved in the past few years, the long term projections of cancer-
related deaths predict that by 2030 pancreatic cancer will become the second most deadly form
of cancer in the United States, surpassed only by lung cancer [191]. At the core of this poor
prognosis are pancreatic cancer’s fast progression, late diagnosis, and lack of viable treatments
[78, 79]. In recent years, the protein kinase D family has received increasing attention as
a possible inhibition target in pancreatic cancer [142, 143, 155, 168, 170]. A number of
compelling in vitro and in vivo (murine) studies have shown PKD-based regulation of both
early acinar-to-ductal metaplasia [143, 168] and later stage pancreatic ductal adenocarcinoma
(PDAC) invasion and metastasis [169, 173]. Additionally, the available literature supports
the notion that the three PKD enzymes control tumor progression and invasion in an isoform-
specific manner and have seemingly opposing pro- and anti-invasive roles [169].
In this work, Panc1 pancreatic cancer cell lines with Crispr/Cas9 knockouts of PRKD1, 2
and 3 genes were used, first time, for systematic studies of in vitro PKD-isoform dependent
pancreatic cancer migration and invasion. Using these modified cell lines, a deeper under-
standing was obtained on the different functions of the three PKD isoforms in cancer cell
motility, contact guidance, MMP-independent invasion, and cell mechanical properties. As
all three isoform knockout lines exhibited unique migratory behavior, they will be discussed
separately.
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9.1 Loss of PKD1 leads to a more invasive pancreatic can-
cer phenotype
The data presented in Chapter 8 suggest that PKD1 activity may inhibit invasiveness in Panc1
cells, as loss of this isoform led to improved cell persistence, enhanced contact guidance and
significant cell softening (see Results Chapter 8). In order to explain the observed changes
in the panc1 phenotype and migration in the absence of PKD1, it is necessary to refer to
unpublished data obtained by collaborators, Dr. Tim Eiseler and Thomas Seufferlein at the
University Clinic Ulm. They measured among other markers expression levels of different
Epithelial-to-mesenchymal (EMT) transition markers and intermediate filament (IF) proteins
in the three different PKD KO cells using qPCR.
EMT transition is one of the main mechanisms of cancer invasion into the stroma [114, 119,
120]. PKD1-dependent EMT inhibition has been shown in various cancer types (see Appendix,
Table A.1). According to the literature, both mesenchymal and epithelial phenotypes have
been observed in different PDAC cell line [171]. In the present study, PKD1 KO pancreatic
cells exhibited mesenchymal characteristics, as qualitative comparison of PKD1 KO cells
with wild type cells showed lack of cell-cell contacts and spindle shaped morphology typical
to mesenchymal phenotype (see Results Chapter 8, Fig. 8.2A). Additionally, immunofluo-
rescence staining of E-cadherin in these cells showed no enhanced expression at cell-cell
junctions (see Results Chapter 8, Fig. 8.3). These observations are in agreement with the
microarray data obtained by the collaborators. They found that compared to control cells,
PKD1 KO cells exhibit a significant upregulation of EMT markers, including N-cadherin,
ZEB2 and vimentin. Combined, these results support the notion that PKD1 can function as
EMT suppressor in pancreatic cancer, which may explain also other observations made in the
different migration experiments of this work.
Panc1 motility was affected as well by the absence of PKD1. Although PKD1 KO cell
speed was not affected, cells migration persistence time was four times higher (see Results
Chapter 8, Section 8.2). It has been reported in multiple cancer cell lines, including PDAC cell
lines, that PKD1 plays an inhibitory role in cancer cell migration (see Apendix, Table A.1).
Dynamic actin polymerization and remodeling is necessary for cell migration [18, 19].
Protrusion of the cell’s leading edge (lamellipodia) is driven by free barbed end formation
of actin filaments [192]. Eiseler et al. reported two independent mechanisms through which
PKD1 controls F-actin polymerization and remodeling [142, 155]. By inhibiting SSH1L
(slingshot protein phosphatase 1), PKD1 inactivates the actin-remodeling protein cofilin at the
lamellipodium, thus inhibiting directed cell migration [155]. Additionally, PKD1-mediated
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cortactin phosphorylation decreases actin dynamics through its affinity to the WAVE2 complex,
resulting in decreased lamellipodia protrusion velocity [142]. Thus, the 4-fold increases in
persistence time of Panc1 cells migrating on 2D glass surfaces (see Results Chapter 8, Fig. 8.5)
might be linked to rapid F-actin remodeling and polymerization in the absence of PKD1.
Panc1 cell deformability seems to be consistently enhanced in the absence of PKD1 in all
the migration assays presented in Chapter 8. PKD1 KO cells had significantly higher aspect
ratios (AR) both on glass and on microstructured PDMS surfaces (see Results Chapter 8, Figs.
8.2C and 8.7C). In the PDMS-based microchannels, cells were able to elongate and permeate
150 µm-long constrictions (see Results Chapter 8, Fig. 8.12). Finally, optical stretching of the
suspended cells revealed 1.6 % higher (statistically significant) Panc1 cell deformability in the
absence of PKD1 (see Results Chapter 8, Fig. 8.13). Changes in biomechanical cell properties
are increasingly being correlated with malignant phenotypes of different cancers [136, 193,
194]. Cell mechanical properties are directly linked to cell cytoskeleton biochemistry and
organization [195]. It has been proposed that cell viscoelastic measurements may be a
marker for malignant transformation, as many studies have revealed a direct link between
the stage of malignancy and cell viscoelasticity [133, 135, 193, 196]. It is thus reasonable
to deduce that changes in the mechanical properties induced by PKD1 knockout may be
advantageous to pancreatic cancer cell invasion potential. Intermediate filaments (IF), such
as keratin, contribute to the maintenance of cell shape and protect cells from mechanical
stresses [197, 198]. PDAC cancer cells express some keratin heteropolymers, with the Panc1
cell line in particular known to express keratin 8 (K8) and keratin 18 (K18) [197, 199]. In
the absence of PKD1, the levels of K8 and K18 in Panc1 cells were downregulated 3.2- and
2.9-fold, respectively (unpublished collaborator data). This downregulation may account
for the observed softening of PKD1 KO cells. This assumption is supported by the studies
done with Sphingosylphosphorylcholine (SPC) treated Panc1 cells [199]. SPC is known to
induce keratin reorganization and reduction of cell peripheral keratin, which significantly
reduces the elastic modulus of the cell. This altered cell deformability has been shown, to
enhance Panc1 cell migration and higher cell invasion in Boyden chamber assays and in
PDMS microchannels [199], [175].
In this work, experiments on Panc1 cell migration on microgrooved surfaces capable of
inducing contact guidance showed that PKD1 knockout caused not only morphological
changes, but also significantly enhanced cell alignment along the grooves (see Results Chapter
8, Fig. 8.8). Improved cell alignment on surfaces with smaller depths (200 nm deep, 2 µm
wide) also led to significantly higher cell speed and better migration directionality (see Results
Chapter 8, Figs. 8.9 and 8.10). Similar behavior has been reported in SPC treated Panc1 cells
[36]. Thus, the downregulation of K8/18 observed in PKD1 KO cells likely plays a role in
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the observed enhancement of contact guidance. The dependence of intermediate filament
expression on PKD1 isoform has not been investigated so far. It may represent a new avenue
through which PKD1 regulates pancreatic cancer invasive features, as along with vimentin
upregulation, alterations or loss of keratin expression are another biomarker of cell EMT
transition [200, 201].
One unexpected result observed in the PDMS microchannel assay was that despite the
significant deformability of the PKD1 KO cells, they did not exhibit enhanced invasion
through the highly confined 3 µm channels. On the contrary, the inability of the nucleus to
squeeze into the narrow channels may have led to a reduction in the number of permeating
PKD1 KO cells and significantly lowered migration speed inside channels with this geometry
(see Results Chapter 8, Figs. 8.11 and 8.12). That interpretation is in alignment with the
widely accepted observation that the nucleus is one of the limiting factors for effective confined
migration. As the largest and stiffest organelle in the cell, it requires significant deformation
to squeeze into the small pores comprising the dense extracellular matrix [202], [203]. The
mechanisms involved in nucleus deformation are not yet fully understood. During migration
and especially confined migration, cell cytoskeleton compresses the nucleus, so the nucleus is
elongated along the migration direction [204–206]. One may speculate, that the softening
of cell cytoskeleton observed in PKD1 KO cells may result in inability of the cytoskeleton
to deform the nucleus, which could explain the inability of the nucleus to squeeze into the
3 µm wide channels. Further investigations would be necessary, to elucidate the changes in
the perinuclear region of these cells, which could attribute to the observed behavior.
9.2 PKD2 knockout reverses EMT but enhances cell prolif-
eration
In the absence of PKD2, pancreatic cancer cells exhibited epithelial characteristics such as
strong cell-cell and cell-surface adherence, and reduced cell speed (see Results, Chapter 8).
These changes might not only be due to the PKD2 KO but could be attributed to PKD1 isoform
activity in the PKD2 KO cells. PKD1 has been shown to promote the epithelial phenotype
in breast and prostate cancer cell lines by upregulating E-cadherin expression [153, 157].
Similarly, PKD2 KO cells, used in the current study, adapted the epithelial phenotype, with
E-cadherin expression at cell-cell borders and cell growth in epithelial-like sheets (see Results
Chapter 8, Figs. 8.2 and 8.3). Additionally these cells exhibited significantly lower single
cell migration speed and stronger cell-cell and cell-surface attachment. As discussed in the
previous section, PKD1 inactivates the actin-remodeling protein cofilin at the lamellipodium
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by inhibiting SSH1L [155]. It has been also reported that in NIH/3T3 fibroblasts PKD1
negatively controls FA dynamics (decrease FA turnover and increase FA maturation) through
phosphorylation of PIP5Klγ enzyme [207]. The presence of highly defined F-actin stress
fibers and large focal adhesions (FA) at the cell lamellipodia observed in immunofluorescent
stainings of PKD2 KO cells may indicate similar function of PKD1 in Panc1 cells in the
absence of PKD2 isoform (see Results Chapter 8, Fig. 8.6). Combined with elevated E-
cadherin levels this function of PKD1 might explain the observation of increased cell-surface
attachment of PKD2 KO cells (see Results Chapter 8, Fig. 8.1).
F-actin and FA spatiotemporal remodeling regulates cell migration and inactivation of the
dynamic changes in both leads to the reduced cell migration speed observed in the PKD2
KO cell line. Despite migrating slower, PKD2 KO cells had 2-fold higher cell persistence
time compared to the parental Panc1 cells. This also is likely a result of altered F-actin and
FA dynamics, as due to reduced F-actin and FA remodeling lamellipodia in the migration
direction may be stabilized for longer time periods.
The hyperproliferation of Panc1 cells in the absence of PKD2 could be attributed to PKD1 sig-
naling as well. Eiseler et al. have shown PKD1 phosphorylation of zinc-finger transcriptional
factor Snail1 in the nucleus which upregulates pancreatic cancer cell proliferation [170].
Upregulaton of E-cadherin and hyperproliferation also explains PKD2 KO cell invasive
behavior in the PDMS-based microchannel assay. The cells were not affected by channel
dimensions and after 24 hours permeated the channels rather in a collective fashion (cell
streaming) retaining their cell-cell contact (see Results Chapter 8, Figs. 8.11 and 8.12). The
channel permeation was then the result of not enhanced invasive behavior but more of volume
exclusion principle caused by the excessive proliferation of these cells.
From the observed behavior of PKD2 KO cells, one may hypothesize that in the parental
cells, where both PKD1 and PKD2 are present, PKD1 regulatory functions are downplayed or
suppressed, as loss of PKD2 leads to the PKD1-governed phonotypical changes in pancreatic
cancer cells.
9.3 PKD3 regulates cell motility
The PKD isoform PKD3 is the least known member of the PKD family. While it has been
reported that PKD3 expression is unchanged in cancerous pancreatic cells compared to their
healthy counterparts [169, 171], there is a lack of literature describing PKD3-specific activity
in pancreatic cancer progression.
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The results in Chapter 8 showed that despite not causing any morphological changes, PKD3
knockout did significantly hinder the motility of Panc1 cells (see Results Chapter 8, Figs.
8.24 and 8.5). PKD3 KO cells saw a reduction in both cell speed and directionality, as
opposed to PKD2 KO cells in which cell speed was significantly reduced but cell persistence
increased (see Results Chapter 8, Fig. 8.2). Additionally, likely due to their reduced migration
speed, PKD3 KO cells did not efficiently permeate PDMS microchannels, either at extreme
(3 µm) or moderate (10 µm) levels of confinement (see Results Chapter 8, Fig. 8.11). This
PKD3-dependent pancreatic cancer cell behavior has not been reported in the literature. As
PKDs are involved in many cellular processes, it is difficult to pinpoint how exactly PKD3
may regulate pancreatic cancer motility. It has been reported that in prostate cancer, PKD3
inhibition impairs cell migration through downregulation or inhibition of MMP9 and growth
factors such as IL-6, IL-8 and GROα , tumor promoting cytokines involved in cancer cell
proliferation, migration and angiogenesis [160]. However, it is clear that PKD3 knockout can
drive notable changes in cytoskeletal organization, as F-actin staining revealed an absence
of the distinct F-actin bundles that are visible in the control cells (see Results Chapter 8,
Fig. 8.6). This observation is supported by the additional result that PKD3 KO cells formed
membrane blebs during 3D cell stretching experiments (see Results Chapter 8, Fig. 8.13),
which could mean either that the membrane has dissociated from the actin cortex or that
the cortex itself has ruptured [208, 209]. Alterations in the normal actomyosin network
could also explain the observed inhibition of cell motility, as F-actin polymerization and
myosin-mediated contractility are the canonical drivers of cell migration.
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Chapter 10
Summary
Immune cell recruitment and subsequent migration is a complex process guided by the
combined effort of many different extracellular cues, including chemical gradients, shear flow
and possibly changes in temperature. In the presented thesis, it was shown that migrating
differentiated HL-60 cells have a nearly constant persistence length at normal (35 – 39 ◦C) and
hyperthermic (39 – 42 ◦C) temperatures, regardless of their extracellular ligand environment.
It could be theorized that the preservation of persistence length confers an advantage to
immune cells migrating at higher temperatures, as they are able to cover more ground in
search of their target independent of extracellular matrix composition. Additionally the
experiments in 2D temperature gradients revealed that motile HL-60 cells could be divided
into two subpopulations exhibiting “positive” (migration towards heat source) and “negative”
thermotaxis (migration towards heat sink). Primary neutrophil thermotaxis has been reported
[188], with two subpopulations of thermotactic cells identified. The first was capable of
reversing course after the thermotactic stimulus was reversed, while the other continued
migration in the same direction. However, this phenomenon has not been investigated further
since its original observation in 1982. Thus, this work provides evidence for a similar behavior
in two subgroups of a model cell line which may hint to a physiological relevant thermotaxis
of immune cells. The findings on 2D surfaces show that neutrophil differentiated HL-60 cells
can be a valuable tool for investigating immune cell thermotaxis, a complex process that is
not yet well understood.
In the second part of the presented thesis, pancreatic cancer motility was investigated in the
absence of each of the three Protein Kinase D isoforms. Using Crispr/Cas9 modified stable
knockout pancreatic cancer cell lines (PKD1 KO, PKD2 KO and PKD3 KO), it was shown
that the loss of each of the isoform had a significant impact on in vitro cell motility and cell
biomechanical properties. Loss of PKD1, in particular, was shown to enhance cell migration
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persistence and contact guidance. Additionally, for the first time, PKD1-dependent regulation
of cell biomechanical properties was revealed, with significant cell softening measure in the
absence of this isoform. Taken together, PKD1 KO cells were shown to exhibit signs of an
invasive phenotype. On the contrary, PKD2 KO cells exhibited characteristics of epithelial,
less invasive, cell phenotype, with significantly lower cell motility and enhanced cell-cell and
cell-surface adherence. And lastly, it was shown for the first time that PKD3 isoform also
influences pancreatic cancer behavior, as PKD3 knockout significantly reduced cell speed and
cell-cytoskeletal stability.
Combined, the presented findings further support the notion that PKD enzymes govern the
invasion-related migration capacity in an isoform-specific way. Furthermore, for pancreatic
cancer therapeutic treatments the loss of PKD2 and PKD3 isoforms could be more beneficiary
than the loss of the PKD1.
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Chapter 11
Outlook
In the temperature-sensitive migration studies a model cell line was used as a substitute for
blood neutrophils.
Though HL-60 cells are an accepted model for neutrophil migration, in a next step, temperature-
dependent cell migration of primary human blood cells should be studied to reveal possible
differences in their behavior. Furthermore, along with neutrophils, other white blood cells
such as T-cells are also involved in the body’s immune reaction. Each of them has various
functions and exhibit different migration characteristics. It would be hence beneficial to look
at the effects of elevated temperatures on all cells involved in inflammation processes.
The changes in actin dynamics and membrane fluidity could explain the ability of HL-60 cells
to maintain the migration persistence length at various temperature ranges. To verify these
observations, further quantitative analysis is necessary. F-actin polymerization dynamics can
be measured for example by performing local FRAP (fluorescent recovery after bleaching)
on actin. Membrane fluidity is customary measured using UV fluorescence polarization (FP)
measurements, which measure changes in membrane-bound fluorophore mobility.
Additionally, further studies have to be done in the physiologically relevant conditions. A
preliminary study of temperature gradients in 3D collagen gels was performed in this thesis,
with the cells showing a tendency to migrate towards the heat source. But due to the limited
time and complexity of the 3D studies, it is difficult to make any definitive arguments without
further in-depth investigations.
Further research in understanding the temperature-sensitive migratory mechanisms of immune
cells will pave the way to better understanding of immune cell functions during disease and
injury.
In the PKD isoform-dependent pancreatic cancer cell invasion studies PDMS-based chips
with microchannels were used. This assay is a versatile tool for single-cell migration studies
in a precisely confined environment. However, it does not account for in vivo cancer cell
invasion by matrix degradation via secretion of matrix metalloproteinases (MMPs). Indeed,
Wille et al. have shown pro-invasive functions of PKD2 in pancreatic cancer cells through
upregulation of MMP7/9 secretion [169]. It is hence important to do further experiments
in ECM gels. As an example, PKD1 KO, PKD2 KO and PKD3 KO cell spheroids can be
imbedded into matrigel, and cell invasive behavior observed over time. Further studies on
the mechanical properties of each of the cell lines are also necessary. In the PKD1 KO
cells the possible biomechanical changes in the perinuclear region due to downregulation
of intermediate filament keratin could explain the delayed “squeezing” of the nucleus when
permeating 3 µm wide channels. Additionally, PKD3 KO cell mechanical properties could
not be measured with the laser-based optical stretcher due to membrane bleb formation under
strain. AFM indentation measurements would allow cell deformability measurements in the
PKD3 KO cells as well as perinuclear region of PKD1 KO cells.
In conclusion, as Protein Kinase D inhibitors are considered to be used in pancreatic cancer
therapy, it is imperative to further study all possible isoroform-mediated changes in pancreatic
cancer invasive behavior. This may lead to better treatment options and higher patient survival
rates.
Appendix
Figure A.1: Blood neutrophils and neutrophil differentiated HL-60 cells have similar migration
speed. Average cell speed 95 % Confidence Intervals of PMN cells isolated from human venous
blood (23.27 4.45 µm/min) and differentiated HL-60 cells (20.67 0.78 µm/min) at 37 ◦C. 20 and
78 cells were tracked for blood neutrophils and differentiated HL-60 cells, respectively. N.S. not
significant.
Figure A.2: Relationship between average cell speed and migration persistence time for differ-
entiated HL-60 cells at control conditions and as a function of temperature. With increasing
temperature cell average speed increases (left axis, red), but migration persistence time decreases (right
axis, green).
Table A.1: Pro- and anti-carcinogenic functions as well as expression level of PKD isoforms in
major cancers. The arrows represent up- and down-regulation respectively. Colors represent isoform
function in tumorogenisis (Pro- Red, Anti-Green)
Type of
cancer
PKD
Isoform
Effect Function Pathways Ref.
Pro Anti-Apoptotic
PKD1-mediated activation of NFκB in response to
loss of cell-cell adhesion and oxidative stress
[163, 164]
Proliferation
The overexpression of PKD1 promotes proliferation
through MERK/ERK pathway
[165]
PKD1 ↓ Migration
Active PKD1-mediated phosphorylation and
inactivation of SSH1L, leading to suppression of
directed cell migration
[155]
Anti Invasion and EMT
PKD1 inhibits EMT by up-regulation of E-cadherin
expression
[153]
Breast
PKD1 inhibits breast cancer cell invasion by
regulating MMPs
[210]
Anti-apoptotic
PKD2-mediated activation of NFκB in response to
reactive oxygen species (ROS)
[211, 212]
PKD2 ↑ Pro Migration
Higher levels of activated PKD2 in drug resistant
MCF7 breast cancer cell line were detected. Loss of
PKD2 significantly reduced cell migration.
[167]
Drug resistance
PKD2 upregulates P-glycoprotein and mediates
multi-drug resistance
[144]
PKD3 ↑ Pro Proliferation Silencing PKD3 in HCC1806 and TNBC cells led to
reduced tumor growth
[213, 214]
Gastric
PKD1 ↓ Anti Proliferation and invasion PKD1 is epigenetically silenced. Loss of PKD1
supports tumor cell migration and invasion.
[156, 162]
PKD2 ↑ Pro Proliferation and invasion Upregulation of PKD2 supports tumor cell migration [156]
PKD1 ↑ (in
mice ker-
atinocytes)
Pro Proliferation In mice models PKD1 promotes proliferation [215]
Anti-apoptosis In mice models reduces UVB-induced apoptosis [216]
Skin PKD2 Anti Proliferation
Loss of PKD-2 resulted in enhanced keratinocyte
proliferation
[217]
PKD3 Pro Proliferation
Loss of PKD-3 resulted in reduced proliferation, loss
of clongenicity and reduced tissue regenerative
ability
[217]
PKD1 ↓ (In
highly
metastatic
cancer cell
lines)
Pro Invasion PKD-1-mediated Wnt5a signaling pathway [166]
Proliferation
PKD1 mediates ERK pathway by complexing with
β 3-integrin, resulting in increased MMP2 and
MMP9 secretion and reduced proliferation
[158]
Prostate
PKD1 ↑ (In
less
metastatic
androgen-
independent
cancer cell
lines)
Anti Migration
PKD1 mediated E-cadherin phosphorylation
resulting in increased cellular aggregation and
decreased cellular motility
[157]
Invasion and EMT
EMT suppression through PKD1-mediated Snail1
phosphorylation
[153]
Carcinogenesis PKD1-mediated AR downregulation [218, 219]
PKD2 ↑ Pro Invasion
Regulation of NF-κB and HDAC1-mediated
expression and activation of uPA and elevation of
MMP9 expression
[154]
Migration
Inhibition of PKD3 impairs migration through
silencing MMP9, IL-6, IL-8 and GROα
[160]
PKD3 ↑ Pro Invasion
Regulation of NF-κB and HDAC1-mediated
expression and activation of uPA and elevation of
MMP9 expression
[154]
Proliferation And Tumor growth
PKD-3-modulates AKT/ERK1 and 2 signaling and
tumor growth
[159]
Brain
(Glioblas-
toma)
Colorectal
PKD2 ↑ Pro Proliferation And Tumor growth
PKD-2 mediates AKT signaling via Golgi
phosphoprotein 3. Loss of PKD2 impairs
proliferation and tumor growth.
[220–222]
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